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Collagen is the major component of the extracellular matrix and is involved in a wide range 
of cellular functions during tissue development and action. At the core of the diverse functions of 
this versatile protein is its remarkable ability to form supramolecular structures through self-
assembly and/or through interactions with other biomolecules. One typical example of such 
supramolecular structure is the fibrils of collagen types I, II and III of the connective tissues. These 
fibrils have staggered arrangement of the laterally associated collagen triple helices – the structural 
unit of collagen – to form long, smooth fibrils with a characteristic 67 nm axial structural feature 
known as the D-periodicity.  
The fibrillogenesis of collagen in tissues is a complex process involving other 
macromolecules; the fibril formation itself, however, is a self-assembly process proceeding from 
the self-association of the triple helix. While many of the structural details of both the triple helix 
and the collagen fibrils have been elucidated, the molecular recognition mechanisms of the self-
assembly process remain poorly understood. Efforts of producing collagen-like, self-assembled 
fibrils through protein design have not been successful.  
 In this work, we describe the self-assembly of a collagen-like periodic mini-fibril from a 
recombinant collagen triple helix. The triple helix, designated Col108, is expressed in E. coli using 
an artificial gene and consists of a 378–residue triple helix domain organized into three pseudo-
repeating sequence units. The Col108 peptide forms a stable triple helix with a melting temperature 
of 41°C. Upon increases of pH and temperature, The Col108 peptide self-assembles in solution 
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into smooth mini-fibrils with the cross-striated banding pattern typical of fibrillar collagens. The 
banding pattern is characterized by an axially repeating feature of ~ 35 nm as observed by TEM 
and AFM. Both the negatively stained and the positively stained. TEM patterns of the Col108 
fibrils are consistent with a staggered arrangement of triple helices with a staggering value of 123 
residues, a value closely connected to the size of one repeating sequence unit.  
A mechanism is proposed for the fibril formation of Col108 with axial periodicity, which 
is stabilized by the optimized interactions between the triple helices in a 1-unit staggered 
arrangement, pointing towards the similar underlying molecular mechanisms i.e. inherent 
sequence periodicity at play in guiding the self-assembly of collagen. Col108 establishes itself as 
a system comparable to native collagen to establish a connection in the self-assembly mechanisms 
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1.1 Collagen, from triple helix to fibrils 
Collagen is the most abundant protein found in the connective tissue11-12. It is most 
prevalent as the fibrous component of skin, bone, tendon, cartilage and teeth in vertebrates. So far 
at least 28 different types of collagen have been reported with 46 different polypeptide 
chains12.Collagen is involved in a wide variety of developmental processes and tissue homeostasis. 
This versatile protein is known for its diversity in cellular functions and has a remarkable ability 
to form supramolecular structural networks like microfilament or fibrils1. Formation of fibrils, i.e. 
fibrillogenesis, is a trait of the family of fibrillar collagen including collagen types I, II, III, V, and 
XI; they form fibrils with characteristic banding patterns8, 13. Among fibrillar collagens, type I 
collagen establishes itself as the major fibril component of bones, tendons, ligaments, skin and 
other tissues and accounts for ~90% of the total collagen content of the body. Type II collagen is 
mostly the structural component of cartilage and the vitreous humor of the eye. Type III collagen 
is predominantly in blood vessel walls, skin, and internal organs and coexists in a fibrillary form 
with type I collagen. Types V and XI are quantitatively less abundant collagens and found in 
association with types I and II collagen fibrils 14.   
Basement membrane collagens, also known as network-forming collagens, are found in a 
particular extracellular matrix which supports epithelial cells, muscle fibers, and peripheral nerves; 
types IV, VIII, XV, and XVIII belong to this family. Types IX, XII, XIV, XVI, XIX are fibril-
associated collagens with interrupted triple helices, i.e. FACIT’s 9, 12, 15. MACIT’s are membrane-
associated collagens with interrupted triple helices, also known as transmembrane collagens, and 
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Type XXV belongs to this family. Type XV and XVIII have multiple triple helical domains and 
interruptions, therefore known as MULTIPLEXIN’s 12. 
Irrespective of the kind of collagen, one characteristic of this protein is that they all have 
the same basic structural element: the triple helix11-12. A collagen triple helix is composed of three 
parallel polypeptide chains in the left-handed polyproline II (PPII) conformation, which further 
supercoil in a right-handed fashion around a common axis.  Every third amino acid residue in the 
polypeptide chain must be a Glycine (Gly). This results in a repeating pattern of the sequence of 
(Gly-X-Y), where X and Y could be any amino acid but is often imino acids proline (Pro) and 
hydroxyproline (Hyp), respectively, at X and Y positions. Glycine residues with their small side 
chains are packed at the center of the triple helix, whereas the side chains of X- and Y- residues 
are exposed to the solvents and are responsible for direct molecular interactions between different 
triple helices during fibril formation16-17. The –NH group of the Gly-, amino acid residue, forms 
an inter-chain hydrogen bond (H-Bond) with –C=O of the X-position residue on the neighboring 
polypeptide chain. These inter-chain or intra-helical H-bonds (one H-bond per one Gly-X-Y- 
triplet) are oriented perpendicularly to the axis of the triple helix and are known as the dominant 
stabilizing factor of the triple helix18-20.  
While all collagens share the same conformation of the triple helix, various types of 
collagen can be differentiated by the interactions between helical and non-helical regions leading 
to the assembly of different supramolecular structures. Type I collagen is very abundant in tendon-
rich tissue and due to this abundance was the first of the collagens to be characterized structurally. 
A triple helix of collagen type I is a heterotrimer formed from two identical α1(I) 
polypeptide chains, and one α2(I) chain having a different amino acid sequence. Each polypeptide 
chain has 1,050 amino acid residues in the non-interrupted (Gly-X-Y) repeating sequence. Each 
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triple helix molecule of collagen (also known as the tropocollagen) has a width of 1.5nm, a length 
of 300nm and a molecular weight of ~285kDa. The triple helices further interact laterally to form 
fibrils of 50-200nm in diameter and more than 10µm long. In these fibrils, adjacent triple helices 
are all in parallel to each other but displaced from one another in a stagger of 67 nm also known 
as the D-period1. There are in total 4.4D periods in one triple helix of native collagen, and the D-
staggered arrangement resulted in the 67nm axial repeat pattern of dark and light bands as observed 
in electron micrographs if the sample is stained negatively: the 0.4D overlap zone (27nm) forms 
the light band, and the 0.6D gap region (40nm) appears as a Dark band in observed electron 
micrographs (Figure 1-1). Structural studies have related this 67nm D-periodicity to defined 
























Figure 1-1 Electron microscopy image of Collagen fibrils. A. Schematic drawing of axial packing 
arrangement of triple helices of collagen in a fibril, B. Negatively stained collagen fibril, C. Positively stained 
collagen fibril. Image adapted from Kadler et al.1  
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1.2 Biosynthesis of collagen fiber 
Collagen self-assembly in vivo is a multistep, complex but well-organized process 8. From 
collagen synthesis to the folding of the triple helix and fibril assembly, many intracellular and 
extracellular steps are involved24 (Figure 1-2). Collagen synthesis begins at the membrane of the 
rough endoplasmic reticulum (RER). Ribosomes synthesize the individual chains. These proto-
collagen chains at the surface of the RER are in a soluble precursor form known as pro-α chains. 
These pro-α chains contain the signature (Gly-X-Y)n sequence and globular N- and  C- propeptides 
which flank the (Gly-X-Y)n  sequence, respectively, on the N-and C-termini
25. 
The C-propeptides control the intracellular assembly of pro-α chains into triple helices i.e. 
procollagen molecules, which can be either homotrimeric or heterotrimeric   The C-propeptides 
play a crucial role in nucleation and folding of the pro-α chains into homo- or heterotrimeric triple 
helical molecules. Further, C-propeptides confer the chain selectivity intracellularly during 
assembly of different types of collagen and are also known to confer solubility to the procollagen 
molecules to prevent fibril assembly during intracellular steps26-27.  
Before the procollagen molecule folds into a triple helix, the peptide chains undergo post-
translational modifications. These modifications require the enzymes: Prolyl hydroxylases28, 
glycosyltransferases29, isomerases, proteinases25 , and oxidases30. Hydroxylation of almost all of 
proline residues to 4R-hydroxyproline (Hyp) in the Y-position and a few lysine residues in the Y 
positions to hydroxylysine occurs. All the hydroxylation takes place in RER. The Hyp in the Y 
residue position provides a stabilizing effect to the triple helical structure31. The conversion of 
proline into hydroxyproline in the Y position in a Gly-X-Y- set leads to the formation of Gly-X-
Hyp triplets at the C-terminus, which in turn acts as a nucleation site for triple helix 
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folding/formation. From the nucleation site, the triple helix folding propagates towards N-
terminus32. 
 Additionally, some of the prolines in the X- and Y- residue positions are hydroxylated to 
3-Hydroxyproline (3-Hyp) instead of 4R-Hyp. What specific roles these residues play in collagen 
structure and formation remains unclear, but in collagen, the locations of 3-Hyp residues are highly 
conserved. The hydroxylation of certain Lys in Y-positions to hydroxylysine (Hyl) residues also 
takes place. The hydroxylation of Lys is significant since the hydroxyl group of Hyl  is a site for 
attachment of carbohydrates and for inter-helical cross-linking13, 33;  which contribute to the 
stabilizing the collagen. Peptidyl proline cis-trans isomerase and protein disulfide isomerase (PDI) 
mediates the formation and rearrangement of inter- and intrachain disulfides in N-and C-
propeptides33.  
Once a procollagen triple helix molecule is formed, it is secreted into the extracellular 
matrix via transport vesicles. In the extracellular matrix, this precursor form of collagen undergoes 
further modifications1, 8, 34-35. Appropriate proteinases cleave respective propeptides, leading to the 
formation of tropocollagen which contains triple helix molecules with only (Gly-X-Y-)n sequence 
repeats. Finally, lysyl oxidase leads to oxidative deamination of specific lysine and hydroxylysine 
residues to allysine and hydroxyallysine to make them available for cross-linking and 
glycosylation36-37. 
The processed tropocollagen molecules self-assemble to form fibrils in the extracellular 
matrix. As the tissues mature, covalent cross-links between neighboring triple helices are formed 
between the α-amino groups of lysine and hydroxylysine residues and the aldehyde group of 
allysine and hydroxyallysine. The cross-links stabilize the fibrils and contribute to the tensile 









Figure 1-2 Major steps in biosynthesis of fibril forming collagen. A schematic drawing of the journey of collagen 
from its biosynthesis in the endoplasmic reticulum into the extracellular matrix via the golgi complex. Intracellular 
steps involve the synthesis of individual collagen pro-α chains by ribosomes, which are injected into the lumen of 
endoplasmic reticulum (ER). Before folding of these biosynthesized chains in the ER, the chains undergo many post 
translational modifications over ~10% of all residues i.e. hydroxylation of proline and lysine residues, glycosylation 
of some hydroxylysine residues, and protein disulfide isomerase(PDI) mediated rearrangements of disulfides in 
propeptides. Collagen folding into a triple helix takes place inside the cell starting at C- terminus. After triple helix 
formation is completed, the procollagen molecules are secreted into the extracellular matrix, where propeptides from 
the N-and C- termini are cleaved and the collagen molecules self-associate to form fibrils. Covalent cross-links are 
formed between different collagen triple helices to stabilize the fibrils. Image adapted from Myllyharju et al.8 
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1.3 In Vitro fibrillogenesis of type I collagen  
Although collagen fibril formation in vivo is mediated by many enzymes present in the 
cell, it has been shown that the triple helices, as the building block of the complicated structure of 
the extracellular matrix, contain much of the required information for fibril assembly25. Thus, fibril 
formation of purified collagen molecules can be studied in vitro in defined conditions. Studies of 
the in vitro fibrillogenesis have provided much insight into fibril formation mechanisms1, 39-40. In 
vitro studies have shown collagen fibril formation to be an entropy-driven self-assembly/ 
polymerization process, which is achieved by increasing the temperature and pH of cold, acid-
dissolved collagen extracts from tissues to physiological conditions40. Reconstituted collagen 
fibrils formed in vitro exhibit all the features observed for fibrils formed in vivo, but are less 
uniform in diameter. This suggests that the regulating factor of fibril size and length is lost during 
the extraction of collagen, or that the mechanism of regulation is different during the generation 
of fibrils from pure solutions6. 
The mechanistic growth of a fibril during in vitro fibrillogenesis has been shown to be 
proceeded by nucleation of monomers and resulting growth to form fibrils of constant length and 
diameter41. In vitro fibril formation is often monitored by turbidity measurements at 313nm. 
In vitro fibril formation starts with a lag period, which is attributed to fibril nucleation42.  
This phase is considered the formation of precursors of the fibril. These precursors grow linearly 
until a critical length is reached. This lag period has important roles in determining the final fibril 
size42-43. The value of the pH of the solution, the ionic strength and ion types present in the buffer, 
and the temperature are a few parameters known to affect the duration of the lag phase. Light 
scattering studies indicated that the initial aggregates show a linear association of collagen 
molecules along the fibril axis instead of lateral organization44.  The second phase of the turbidity 
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time curve is known as the growth phase where the microfibrils formed during the lag phase grow 
linearly and laterally. The increased size of the fibrils is the reason for observed solution turbidity 
(Figure 1-3). The last phase is the plateau phase in which fibrils with an axial repeat pattern, i.e. 
D-period, are readily observable39. 
Electron microscopy and light scattering techniques have further confirmed in vitro 
fibrillogenesis to be a multi-step process in which linear aggregate formation is followed by lateral 
growth40. Quasi-elastic light scattering studies of collagen solutions have indicated that in early 
stages of in vitro fibrillogenesis, 4.4Dstaggered interactions are already present. Also, electron 
microscopy studies have supported the presence of 4.4D staggered dimers during early stages of 
in vitro assembly of collagen45. 
It is not completely understood what properties of the triple helix lead to the D-periodicity 
of the self-assembled fibrils. Hulmes and colleagues have shown by using a computer-aided 
sequence alignment approach that by a mutual staggering of multiple units of 234 residues, or 
multiples of a D-period, hydrophobic and charged interactions between neighboring triple helices 
were maximized22. Therefore, it has been proposed that maximized interaction is the driving force 
which leads to spontaneous self-assembly of collagen triple helices into fibrils with the precise 
structural specificity of a 67nm D-period. However, due to the complexity of fibrillogenesis, the 
critical role of known factors in fibril formation are difficult to isolate and evaluate. The possible 
contribution of other factors to the features of the supra-molecular fibrous structure of native 
collagen have also been explored: the role of N- and C-telopeptides in fibrillogenesis, which are 
considered essential for anchoring ends of neighboring collagen molecules41, 46, the role of 
aromatic residues that contribute to CH—Π interactions47; and the role of hydroxyproline, which 
adds additional stability due to stereoelectronic effects and hydration network4, 48. The fundamental 
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biological process is still poorly understood, and much work is needed to advance the field of 
collagen research. Unfortunately, our current understanding of the molecular recognition 
mechanisms involved in self-assembly of collagen is insufficient and has limited the efforts of 




































Figure 1-3 Kinetics of in vitro self-assembly of type I collagen fibrils. (i) Turbidity increases significantly as 
collagen self-assembly into fibrils takes place. Experiments were conducted for collagen solution 0.5mg/mL, pH 6.9 
and temperature 21°C. Inset schematics show that in vitro self-assembly of collagen starts as triple helical collagen 
molecules and ends with well-ordered collagen fibrils that form gel. A. an initiation step where soluble collagen 
aggregates formation takes place and these aggregates/ precursors grow linearly until a critical length is reached. B. 
Growth of the fibrils takes place in this step leading to linear and lateral growth of fibrils. Solution turbidity increases 
during this step. C.  A plateau is the last step when native banded fibrils are obtained. (ii) TEM image of a self-
assembled collagen fibril showing dark-light D-banding pattern. Image adapted from Shayegan et al.6 
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1.4 Peptides as model systems for collagen 
The understanding of roles/contributions of the factors mentioned above towards molecular 
recognition mechanisms of this peculiar assembly of collagen has been explored using synthetic 
triple helical peptides by different researchers10, 49. 
Collagen-like peptides have played a very significant role in our current understanding of 
collagen. They were essential for elucidating the structure of the triple-helical conformation of 
collagen. These polypeptides also informed our understanding of how sequence drives the 
structure and function of native collagen. 
A conceptual outline of the structure of the collagen triple helix was developed from 
structural studies of polyproline50 and polyglycine51. These expositions provided insight into the 
fundamental stabilizing interactions. Once the structure of collagen triple helix was resolved, it set 
the stage for synthesis and characterization of collagen-like oligopeptides and polypeptides52-56. 
Deriving the relationship between conformation, amino acid sequence, and stability of the triple 
helix was the aim of such studies. These studies highlighted the significance of residues in X-and 
Y-positions of the Gly-X-Y sequence and the role of the solvent in stabilizing the triple helix. X-
ray crystallography was used to explore the high-resolution structures of collagen-like peptides. 
(PPG)10 was the first 30-mer peptide whose crystal structure was solved by Okuyama et al.
57. 
Hydration network58-59, hydrogen bonding60-61 and helical parameters57 were some of the many 
features that were addressed by high-resolution structures of collagen-like peptides. The sequence 
dependency of the triple helical parameters was decoded by studying structures of peptides with 
different sequences. Variability in the super-helix twist / helical symmetry in the imino acid rich- 
and poor- peptides was highly significant, indicating a high probability of having subtle variations 
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in the helical conformations62-64. This difference in helical symmetry can be used for fibril 
assembly or functionalizing collagen with other molecules. 
Further advances from sequence-structure findings included the structural consequences of 
pathological mutations. Host-guest peptides of sequence (GOP)3-G-X-Y-(GOP)4 were used to 
relate the amino acid sequence of the collagen triple helix to its thermal stability65. Triple-helical 
stabilization propensities of all 20 residues in the X- position of the G-X-O guest triplet, and for 
20 residues in the Y-position of G-P-Y triplets were evaluated. Also, interactions between X-and-
Y- residues in a G-X-Y guest triplet along with interactions between neighboring triplets G-X1-
Y1-G-X2-Y2 were similarly measured. The results culminated in a collagen stability calculator. 
The relative stability predictions from the algorithm and the observed experimental values of 
melting temperature differ by only 3-4°C. Evaluating the effects of single point mutations in the 
X- and Y- positions is a common application of this algorithm. Consequently, this algorithm has 
been very useful in protein design. 
Collagen-like peptides have played a significant role in providing conceptual information 
of the effects of Gly mutations in collagen.  It is well known that abnormal degradation or cross-
linking of collagen can lead to many common diseases like arthritis and diabetes. Also, specific 
genetic mutations in collagen can lead to rare genetic disorders. One example of a collagen-related 
genetic disease is Osteogenesis Imperfecta (OI), which has a clinical manifestation of bone 
fragility resulting from a mutation in type I collagen66. In recent years, it was found that at least 
682 Gly missense mutations in α1 and/or α2 chains in the Type I heterotrimer cause bone 
fragility67. The severity of the disease is dependent on factors like location of the mutation with 
respect to the  C-terminus; type of residue that is replacing glycine; chain in which the mutation 
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occurs etc.66-68. The effect that these mutations have on the folding of the helix has also been 
studied using host-guest triple helical peptides69-72. 
While collagen-like designer peptides have been very successful in providing a detailed 
story of the collagen triple helix at a molecular level,  much emphasis has not been placed on 
understanding the higher order assembly of such collagen peptides. The abundance of collagen in 
the extracellular matrix, its structural integrity and its role in cellular growth and tissue 
development, makes it an ideal candidate for biomedical applications such as drug delivery, tissue 
regeneration, and bone repair. However, the risk of immunogenic responses as well as the transfer 
of toxic agents like prions, pose challenges in the commercialization of natural collagen. Another 
drawback of natural collagen is that its structure cannot be modified in a sequence-specific manner. 
Also, natural collagen scaffolds when used as transplants in the extracellular matrix cannot 
withstand the collagenase-induced degradation. Some of these challenges are addressed through 
nano- and macro-assembly strategies, which rely on short peptides that are easily synthesized and 
can self-assemble into higher order structures upon physiological conditions 
Brodsky et al. have initially reported a higher order aggregated structure of a 30 residue 
long (POG)10 unmodified collagen peptide
4.  This research focuses on elucidating the similarities 
between natural collagen self-assembly and the self-association of this small peptide4, 49. This 
study underlines the critical link between peptide and collagen self-association - the role of 
hydroxyproline in mediating the lateral interactions between the building blocks of self-assembly, 
i.e., triple-helical molecules48. The aggregates of (POG)10 show no morphological similarity to 
collagen fibrils but provide the grounds for the studies focusing on the development of synthetic 
collagen fibers (Figure 1-4A). Techniques like chemical cross-linking73 and native chemical 
ligation9 have also been used to generate polymerized collagen peptides with poly-(POG) sequence 
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(Figure 1-4B). Both of these methods produced nanofiber-like structures, which were longer than 




















Figure 1-4 Higher order Assembly of unmodified collagen-like peptides. A. TEM image of aggregates formed 
after self-assembly of (Pro-Hyp-Gly)10 peptide B. Native chemical ligation mechanism combining a C-terminal 
thioester and N-terminal cysteine facilitating polymerization of Cys-Hyp-Gly-(Pro-Hyp-Gly)9 peptide and fibers 
formed from polymerized peptide. Image A adapted from Kar et al. 4. Image B adapted from Paramonov et al.9 and 
Przybyla et al.10. 
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Additional modified collagen peptides include functional incorporations at one or both 
ends. One popular modification is cysteine knots, which are used to cross-link three collagen 
peptide sequences in a triple helix, covalently. The cysteine knots increase the thermal stability of 
the triple helix and induce the generation of higher order collagen peptide assemblies using 
heterotrimeric helices74-77. Koide et al. have shown that using disulfide linkages between three 
(POG) based 24-mer peptides results in staggered overhangs of 12 and 13 residues, allowing for 
self-complementary supramolecular assembly of these peptides into 0.6 and 14µm particles2 
(Figure 1-5A). Koide et al. have further modified this prototype peptide to generate staggered 
overhangs of 15- and 18 residues78. These peptides, unlike the prototype, have managed to produce 
hydrogels. However, a comparison between this hydrogel and native collagen gel has never been 
studied. Similarly, Raines et al. have used disulfide linkages to tether collagen peptides, resulting 
in higher order assemblies7 (Figure 1-5B). 
In 2009, Kiick et al. had reported a hydrophilic, non-repeating and hydroxyproline-lacking 
collagen mimetic peptide that includes a C-terminal Cys-knot and forms covalently crosslinked 
homotrimers. Strikingly, the C-terminal Cys-knot was not critical for the assembly79. The 
synergistic effect of hydrophobic clusters of Gly-Pro-Pro sequences at both termini and the 
presence of charged residues facilitating electrostatic interactions were sufficient to guide the 





Figure 1-5 Cysteine knots in controlled supramolecular assembly of heterotrimeric helices of collagen-like 
peptides. A. Assembly strategy of self-complementary collagen like peptides designed by Koide et al.2; B. Assembly 
strategy of staggered collagen sequence designed by Raines et al.7. Image adapted from Przybyla et al.10. 
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Maryanoff et al., Raines et al. and Brodsky et al. used a sticky end approach relying on 
noncovalent hydrophobic interactions to promote the self-assembly of collagen peptides (Figure 
1-6). These groups used terminally placed aromatic residues on designed collagen peptide 
sequences. Maryanoff et al. and Raines et al. engineered the peptide assembly by an end-to-end 
stacking of triple helices, which was caused by ordered, stacking hydrophobic interactions between 
the terminally placed aromatic residues5, 80-81. Brodsky et al. also demonstrated the collagen 
peptide assembly using terminally positioned aromatic residues47. In such assemblies, along with 
π-π stacking interactions, the CH- π interactions between the terminally positioned aromatic 
residue at the end and imino acids within the adjacent triple helix occur. Both of these self-
assembling strategies relied on hydrophobic interactions producing self-assembled supramolecular 














Figure 1-6 Sticky-end assembly strategy relying on hydrophobic interactions from terminally placed 
aromatic residues in collagen-like peptides. A. Sequence design of a collagen like peptide with hydrophobic 
residues at both termini; a pentafluorophenylalanine residue at N-terminus and a Phe residue at C-terminus of 
(Pro-Hyp-Gly)10 peptide. B. TEM image of assembled collagen fibers5. Image adapted from Przybyla et al.10 
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Electrostatic interactions have also been used in generating collagen mimetic microfibers. 
Chaikof et al. have created a homotrimeric peptide with three different Gly-X-Y domains flanked 
with a positively charged amino acid (Arg) or a negatively charged amino acid (Glu)3). This 
collagen peptide domain has a poly-(POG) sequence as a hydrophobic core, which increases the 
thermal stability of this peptide design (Figure 1-7). The electrostatic interactions of terminally 
positioned, charged residues serve a two-fold purpose: 1) to facilitate the linear oligomerization 
within the fibrils; and 2) to promote the staggered orientation between neighboring triple helices. 
However, one critical step in achieving this observed self-association is thermal annealing- heating 












Figure 1-7 Assembly strategy of collagen-like peptides relying on electrostatic interactions. A. Sequence design of 
(Pro-Arg-Gly)4-(Pro-Hyp-Gly)4-(Glu-Hyp-Gly)4 collagen peptide B. Model showing charged residues Arg and Glu 
facilitate linear assembly of triple helix through electrostatic-interactions and D-periodic collagen peptide fiber 3. Image 
adapted from Przybyla et al.10 
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Additionally, Chmielewski et al. reported the directional assembly of collagen-based 
peptides into large and well-ordered structures with tunable shapes promoted by metal-ligand 
interactions82-83. 
Over time, our understanding of the structure of collagen, especially its biological diversity, 
has promoted its potential as a novel biomaterial. From regenerative medicine to stem cell 
differentiation, the biomedical importance of collagen is apparent. Site-specific modifications in 
collagen-like peptides allow researchers to use biological and physical properties of native 
collagen and functionalize modified biological sequences to create useful biomedical scaffolds. 
However, mimicking natural collagen self-assembly in the actual sense is still a long journey. The 
size of these functional collagen peptides does not match the real length of native collagen, and 
therefore, does not provide complete insight into the molecular mechanism of the self-assembly of 
native collagen. While this does not preclude the development of functional scaffolds, an improved 
understanding of native collagen assembly would contribute substantially to the basic research 















Fibril formation studies using Commercial rat tail type I collagen 
2.1 Introduction 
 In vitro assembly of collagen under physiological conditions results in fibrils formed with 
the characteristics of those observed in vivo. The similarities found between native fibrils and 
reconstituted fibrils from purified type I collagen were the driving force for studies focused on 
understanding collagen self-assembly. The effects of factors such as pH  between 5.0-8.5, ionic 
strength between 0.1and 0.8,  temperatures between 15-37°C, the identity of ion species in 
solution, the presence of surfactants, etc. on the self-assembly process have been characterized42, 
84-89. Collagen fibrillogenesis is an endothermic, thermodynamically favorable and entropy driven 
process90-91. Theoretical models implicate hydrogen bonding and hydrophobic and electrostatic 
interactions as the stabilizing factors of self-assembly. 
It is well known that temperature affects the fibrillogenesis rate as well as the morphology 
of the fibrils. Self-assembly of collagen i.e. transition of collagen from a liquid phase to a solid 
phase resulting in the particular D-periodic feature of fibril morphology was explained as a 
physical process of diffusion-limited aggregation (DLA)92. Using this model, Parkinson et al. 
showed that the fibril formed using their model resembled the fibrils formed at a high temperature 
of 37°C. One of the major assumptions made in this example was that a total of 4.4D periods exist 
per collagen molecule; all the staggers (0D, 1D, 2D, 3D or 4D) were considered to have an equal 
stabilizing effect on the fibril structure. During warming, collagen monomers diffuse slowly onto 
the formed micro-fibril or nucleation aggregate. Spontaneous, thermodynamically favorable and 
diffusion-limited aggregation at warming temperatures can lead to the formation of well-organized 
25 
 
and long fibrils. Regarding warming the neutralized collagen solutions, it was observed that the 
collagen solutions at either 26°C or 37°C led to the formation of gels and fibrils with the distinct 
D-banding pattern.  It has been reported that increases in temperature favor the release of structured 
water from the hydrophilic residues to bulk solution93. Also, increases in temperature facilitate 
alignment of protein side chains to the most favorable attractive configuration94.  
In vitro fibrillogenesis of collagen has been extensively studied using electron microscopy 
with the aim of developing insights into the complex molecular mechanisms involved in natural 
collagen fibrillogenesis. The variation in the diameter of fibrils formed in vitro is a common 
observation.  Controlling the dimensions of fibrils formed during these experiments is difficult. 
Under high salt conditions, the fibrils formed at both temperature conditions have shown smaller 
diameters compared to fibrils formed at low salt concentration. This observation is in agreement 
with a study reported by J.R.Harris et al.95.  
Ion species in the buffer also have a strong influence on fibrillogenesis93-94, 96-99. At neutral 
pH and low salt conditions, it has been shown that the dibasic phosphate (HPO4
2-) binding sites 
per collagen molecule increase relative to high salt conditions97. Phosphate anions are either 
directly bound to the collagen or present as free anions in the interstitial water. Binding of dibasic 
phosphate to the collagen fibrils is known to facilitate the longitudinal growth of collagen fibrils 
as phosphate binding has been shown to affect the electrostatic interactions significantly. Also, 
dibasic phosphate anion binding has a weak promoting effect by reducing the critical concentration 
required for collagen fibrillogenesis100. 
The purpose of our study on fibril formation using rat tail type I collagen was to find the 
optimal experimental conditions to guide the study of the fibril formation using our designed 
collagen-like peptide. We wanted to identify the optimal conditions regarding salt concentration 
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and incubation temperature for fibril formation. The method for fibrillogenesis was adapted from 
the assembly procedure used by Piez et al.39. The fibril formation of the type I collagen isolated 
from the rat tail tendon was studied in two different salt concentrations: high salt (135mM NaCl) 
and low salt (67.5mM NaCl) (after mixing, see section 2.2 for details) and at two different 
temperatures: 26°C and 37°C.  
2.2 Methods 
 The buffer conditions used in this experiment were 5mM acetic acid (HAc, pH 4) for 
dissolving collagen; double strength neutralization buffer (60mM TES, 60mM Na2HPO4, pH 7.4) 
with high salt (270mM NaCl) and low salt (135mM NaCl) for fibril formation experiment. The 
final concentration of buffer after neutralizing the acidic solution of collagen is 2.5mM HAc, 
30mM TES, 30mM Na2HPO4 and high salt (135mM NaCl) and low salt (67.5mM NaCl) both at 
pH 7.4. 
The rat tail collagen (Sigma-Aldrich C7661) was dissolved in 5mM Acetic acid (HAc) to 
the concentration of ~1mg/mL (estimated by weight) and equilibrated overnight at 4°C to ensure 
the complete dissolution and folding of the protein. To start fibrillogenesis, this acidic solution of 
collagen was mixed in 1:1 equal volume ratio with a double strength (2X) neutralization buffer. 
The final concentration of salt after mixing was 135mM (the high salt condition) or 67.5 mM (the 
low salt condition) NaCl, pH 7.4. The buffers were pre-chilled on ice, and mixing was completed 
under cold conditions. The sample was transferred to a water bath set at 37°C. The process of fibril 
formation was monitored by measuring the turbidity at different time intervals. Samples to be used 
to study the formation of fibrils under transmission electron microscope were prepared after a 
plateau was observed in the turbidity curve. The turbidity change was monitored by recording 
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optical density of the sample at 313nm using a DU800 spectrophotometer. The raw data was 
plotted to obtain a turbidity curve.  
The Transmission Electron Microscope (TEM) imaging samples were prepared on 400 
mesh formvar-carbon coated grids and imaged under a JEOL2100 TEM. 3µL of the sample were 
placed on the grid and allowed to sit for for 100 seconds. The grids were washed using deionized 
water for 5 seconds. The grid samples were stained with 3µL of 1 % Phosphotungstic acid for 100 
seconds, and the grids were rinsed again with deionized water for 5 seconds. The samples were 
left to air dry before imaging.  
The same protocol was used for fibril formation at 26°C except for the water bath 
temperature, which was set at 26°C. 
2.3 Results 
2.3.1 Effect of temperature and salt concentration on the turbidity curve of fibril formation 
  The fibril formation was monitored by the optical density at 313 nm, which has been 
shown to be comparative to the amount of product that is assembled42. The turbidity curves 
obtained in the experiment using high salt (135mM NaCl) and low salt (67.5mM NaCl) 
neutralization buffer are shown in Figure 2-1A. A typical sigmoidal curve with a lag phase, growth 
phase, and a plateau region was observed40. No noticeable increase in turbidity during the lag phase 
was observed. Turbidity increased very quickly during the growth phase and the plateau,  
remaining constant; confirming the nucleation-polymerization process.  
At high temperature, i.e. 37°C, the plateau was reached in about 45 minutes in both low 
and high salt conditions. However, the lag phase under a high salt condition was observed to be 
shorter than the lag phase in low salt condition. The growth phase, where the linear and lateral 
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growth of fibrils takes place, appeared to start earlier in high salt conditions as compared to low 






Figure 2-1 Turbidity curves showing an increase in optical density with time as collagen 
fibrils form. The concentration of the starting acidic solution of collagen was 1.0mg/mL. The 
starting sample was brought to physiological conditions by mixing in 1:1 volume ratio with 
double strength high salt (Red circles) or low salt (Blue circles) neutralization buffer (pH 7.4). 
The final concentration of the sample after neutralization is ~0.5mg/mL. A. The sample 
incubated at 37°C. B. The sample incubated at 26°C. 
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 The turbidity curve observed at 26°C shown in Figure 2-1B was comparable to that 
observed at 37°C. It clearly showed a sigmoidal curve with a lag phase, a growth phase, and a 
plateau region. At low temperature, the total time for fibrillogenesis to reach plateau was observed 
to be almost 5 times longer than at high temperature. The total time for fibril formation at low 
temperature using high salt concentration in neutralization buffer is ~200 minutes, and for the 
sample neutralized with low salt concentration was ~250 minutes. The effect of changing the salt 
concentration (on turbidity) was not prominent at low temperature. 
From Figure 2-1, it is clear that under high and low salt conditions, the fibrillogenesis rate 
was influenced by temperature. At high temperature, collagen fibrillogenesis proceeded at a faster 
pace compared to the same process conducted at low temperature. Also, the total time of the lag 
phase before the onset of growth phase was observed to be greater for the sample neutralized with 
low salt buffer as compared to high salt buffer. Electrostatic interactions have long been considered 
to play a role during self-association of the triple helix. However, these results show that the effects 
of salt on fibrillogenesis are still not fully understood96-97. The time to reach a plateau of fibril 
formation completion at both high and low salt conditions, as seen from the turbidity curve, was 
comparable.  
2.3.2 Effect of temperature and salt concentration on fibril morphology 
The morphology of the fibrils formed under different conditions  -low salt solutions and 
high salt solutions incubated at 37°C or 26°C was examined using TEM.  For samples incubated at 
37°C or 26°C, the D-period of the fibrils was clearly distinguishable after staining the sample with 
either 1% Phosphotungstic acid or 1% Sodium Phosphotungstate. The majority of the fibrils 
appeared smooth, unbranched, and very long. It was difficult to follow the length of a fibril from 
end to end. However, the diameter of formed fibrils was able to be characterized. 
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For high salt containing samples incubated at high temperature (37°C), the diameter of the 
formed fibrils was observed to be 29-58nm (Figure 2-2). And, at low temperature (26°C), the 
fibrils formed were 30-85nm in diameter (Figure 2-3). In Figure 2-2(i) the fibrils were stained 
negatively with 1% sodium phosphotungstate staining reagent. The fibril surface appeared smooth 
and clear D-banding pattern on the fibril was observed. Salt/ staining reagent deposits were clearly 
seen on the formed fibrils. In Figure 2-2(ii), it can be seen that samples stained with 
phosphotungstic acid were stained positively. These fibrils did not appear smooth, and a lot of 
backgrounds (probably coming from salt/staining reagent) besides the fibrils was observed on the 
grid. In Figure 2-3, different areas of the grid are showing the presence of D-banded fibrils. Some 
non-banded clusters of fibrils were seen in the background. 
 For low salt-containing samples incubated at high temperature, the fibrils formed were of 
50-127 nm in diameter (Figure 2-4) and for samples incubated at low temperature the diameter of 
the fibrils observed was 40-92nm in diameter (Figure 2-5). In Figure 2-4(i), for samples stained 
with 1% sodium phosphotungstate, the fibrils appeared to have a clear D-banding pattern 
irrespective of a lot of backgrounds. For the samples stained with 1% phosphotungstic acid (shown 
in Figure 2-4(ii)), the fibrils appeared to have a very clear and defined D-banding pattern. But 
some salt/staining reagent deposit was seen on the fibrils as well. For samples incubated at a low 
temperature in low salt conditions (Figure 2-5), the fibrils appeared to have a very clear D-banding 
pattern, and the fibrils appeared very smooth and with no extra salt/stain deposit. 
Comparing different salt conditions and different incubation temperatures, it appeared that 
a low salt condition seems to work better to give well-defined D-bands on the fibrils. Also, the 
salt/staining reagent deposit was not so significant in the low salt condition. Incubation 
temperature variation did not bring any significant changes to the fibril morphology at a low salt 
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condition. Samples showed both positive and negative staining patterns using the same heavy 
metal staining reagent. These estimates were based on 7-16 measurements of a single grid prepared 











Figure 2-2 Transmission electron micrographs of self-assembled collagen fibrils in high salt (135mM NaCl) buffer and 
at high incubation temperature (37°C). Samples for Electron microscopy were taken after a plateau phase was reached 
during fibrillogenesis as observed using turbidity curve studies and stained with (i) 1% sodium phosphotungstate and (ii) 1% 
phosphotungstic acid. The banding pattern observed in the fibrils is similar to that of fibril formed in vivo. (i) (A) and (B) show 
different magnifications and different areas of the grid. A 67nm D-period on the fibrils is clearly seen in the negatively stained 
fibrils. Fibrils appear smooth and long. (ii) (A) and (B) show different magnifications and of the same area. Samples stained 




Figure 2-3 Transmission electron micrographs of self-assembled collagen fibrils in high salt (135mm NaCl) buffer and 
at low incubation temperature (26°C). Samples for electron microscopy were taken after plateau is reached in turbidity 
curve studies (see above) and stained with 1% phosphotungstic acid. A negative staining pattern was observed in the fibrils. 
The fibrils formed were long and uniform in diameter. Also, some non-banded fibrils were observed in the background. (A), 




Figure 2-4 Transmission electron micrographs of self-assembled collagen fibrils in low salt (67.5mm NaCl) buffer and 
high incubation temperature (37°C). Samples for electron microscopy were taken after plateau is reached in turbidity curve 
studies (see above) and stained with (i) 1% sodium phosphotungstate and (ii) 1% phosphotungstic acid. The banding pattern 
observed in the fibrils is similar to that of fibrils formed in vivo. (i) And (ii), (A) and (B) show different magnifications and 










Figure 2-5 Transmission electron micrographs of self-assembled collagen fibrils in low salt (67.5mm NaCl) buffer and 
low incubation temperature (26°C). Samples for electron microscopy were taken after plateau is reached in turbidity curve 
studies (see above) and stained with 1% sodium phosphotungstate. The banding pattern observed in the fibrils is similar to 
that of fibril formed in vivo. (A), (B) and (C) show different areas of the grid and different fibril areas. The presence of a 67nm 
D-period on the fibrils can be seen clearly. Fibrils appear smooth, long and some non-banded fibrils in the background are 




The fibril formation experiments using commercial rat tail collagen were conducted with 
two different neutralization buffer compositions and at two different temperatures. The fibril 
formation appears to be faster at high temperature. The fibril formation at high salt buffer 
conditions also appear to be faster than at low salt, but the differences disappeared at low-
temperature incubation. No significance difference was observed in the morphology of the fibrils, 
but the D-periods of the fibrils in low salt buffer were better defined compared to those incubated 
in high salt buffer. At low salt conditions, there were also less salt deposits and less overall 
background on the TEM grids. Based on these observations, we decide to use the low salt 
neutralization buffer to study the fibril formation process of the designed peptides. Both 37°C and 
26°C appear to be adequate for fibril study. The fibril formation for Col108 would be studied at 












Col108 - a designed collagen-like fibril-forming peptide 
3.1 Introduction to Sequence design of Col108 
Col108 is a designed collagen-like peptide that contains a total of 417 amino acid residues. 
Out of these 417 residues, 378 amino acids residues are in a non-interrupted Gly-X-Y repeating 
sequence – the Gly-X-Y domain. The triple helical domain of Col108 has an inbuilt sequence 
periodicity, i.e. it contains three segments of pseudo-identical amino acids sequences. Each 
segment, herein called a sequence unit, contains 108 residues, referred to as the ‘Col domain’ 
(hence the peptide is named Col108), which is a composite of residue sequence selected from the 
alpha I chain of type I collagen; they are residues from positions 242 through 256, 296 through 
322, 434 to 478 and 515 to 535 of the collagenous domain. These residues were selected based on 
their relatively high propensity for triple helix stabilization according to the work of Brodsky et 
al.65.  
Each sequence unit also contains a (Gly-Pro-Pro)4 sequence the N-terminal to the Col 
domains. The purpose of incorporating the (Gly-Pro-Pro)4 was to increase the stability of the 
peptide65. An additional (Gly-Pro-Pro)4 was inserted at the C-terminal of the entire Gly-X-Y 
domain which mimics the C-terminal imino acid rich region of fibrillar collagen  thought to play 
a role in facilitating the triple helix formation with the correct chain register101-102. Also to ensure 
the formation of the stable triple helix, a sequence of (-Gly-Pro-Cys-Cys) was incorporated at both 
the N- and C-termini. The cysteine residues were expected to form inter-chain disulfide bonds, 
known as the Cys-knots to covalently link three Col108 monomer chains in a triple helix75, 103. A 
foldon domain of 27 residues from bacteriophage T4 fibritin was incorporated at the C-terminus 
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to serve as a nucleation site for the triple helix folding. The foldon domain forms a stable, compact 
three-stranded beta barrel104-105.The complete amino acid sequence of Col108 is shown in Figure 
3-1. 
In summary, the Col108 peptide is comprised of three pseudo-identical sequence units. 
Each unit has a total of 120 amino acid residues containing a (GPP)4 and a 108 residue ‘Col 
domain. The sequence has one additional set of (GPP)4 at the C-terminus, and the central repeating 
unit contains an additional pair of the Gly-X-Y triplet (GSR and GTP) introduced by restriction 
























Figure 3-1. The amino acid sequence architecture of peptide Col108; (i) Four different residue sequence selections 
from alpha-1 chain of type I collagen indicated by residue position and identity of the corresponding 36 Gly-X-Y 
triplets in Col domain. (ii) Col108 sequence design corresponding to gene construct; three different amino acids 
sequence sets encoded by corresponding codon sequences which are ligated using restriction endonuclease enzyme 
site; the three repeating units of Col108 are marked with double headed arrows The GS, SR and GT in boxes are the 
residues coming from the restriction enzyme sites. (iii) The amino acid sequence of Col108 shown in detail. 
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3.2 Construct of Recombinant plasmid for Col108 
The expression plasmid was constructed by ligating three separately synthesized DNA 
sequences. All sequences were acquired from GenScript Corp.  The three sequences were designed 
for the convenience of the gene manipulation and were not in the exact correspondence to the three 
sequence units in Figure 3-1. The three genes were flanked by restriction enzyme cutting sites 
used for gene ligation. In order to avoid any interruptions in the Gly-X-Y repeating sequence 
pattern of the gene product, additional bases were inserted in conjunction with the restriction 
enzyme sites, and in combination, these sequence inserts would translate to a Gly-X-Y amino acid 
triplet.   
The first gene encodes for a Cys-knot (-GPCC), a (GPP)4 repeat, the first Col domain , and 
a second set of (GPP)4 repeats. It also includes a BamHI restriction site at the 5’-end 
(___GGATCC) and a (GGCTCTAGA) nucleotide sequence at the 3’-end encoding the amino acid 
sequence Gly-Ser-Arg; corresponding to an Xba1 restriction enzyme site.   
The second gene encoded for the second Col-domain and was flanked by an Xba1 site at 
the 5’-end and the sequence GGTACCCCG) at the 3’ end; corresponding to a Kpn1 site, and the 
final base sequence is ultimately translated into the amino acid triplet Gly-Thr-Pro. 
The third gene supplied a Kpn1 restriction site at the 5’-end (codon sequence 
GGTACCCCG) , the third set of (GPP)4, the third Col-domain, the C-terminal (GPP)4, a sequence 
for a Cys-knot, the foldon domain, and an EcoR1 site at the 3’-end. 
The three genes (or Gene 1, Gene 2 and Gene 3) were treated with a corresponding 
restriction enzyme and ligated to form the final COL108 gene having BamH1 and EcoR1 
restriction sites on the 5’-and 3’-ends, respectively. The resulting gene construct is shown in 
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Figure 3-2.  The gene insert was cloned into a modified pET32a(+) plasmid between the BamH1 
and EcoR1 sites. In this modified plasmid, the initial Thioredoxin and His-tag positions in the 
original pET32a(+) were reversed  , and the 3’-end His-tag was removed. The sequence of Col108 
gene was confirmed by DNA sequencing using primers from 5’-end (T7-promotor primer) and 3’-








































Figure 3-2. The gene construct of peptide Col108. The three genes and corresponding to the amino acid sequence 
are shown in red, blue and green boxes. Respective restriction enzyme sites flanking each gene at 5’ and 3’ are also 
shown in the boxes confirming the ligation mechanism used in synthesizing gene of Col108. Stop codon EcoRI is 




Optimization of the Expression and the Purification of Col108 
4.1 Introduction 
The peptide Col108 was expressed in E coli under the control of the Lac operon. The direct 
gene product of Col108 is a fusion protein that includes a His-tagged thioredoxin at the N-terminus 
and a thrombin cleavage site for the removal of the tag (Figure 4-1). The purification of Col108 
involves three steps: (i) separation of the His-tagged fusion protein from the cell lysate; (ii) 
enzymatic cleaving of the His-tagged thioredoxin from Col108 peptide using thrombin ; and (iii) 
the final separation of the Col108 peptide from the thrombin and the His-tagged thioredoxin by 
High performance liquid chromatography (HPLC). The purified Col108 is then, stored as 
lyophilized powder. The buffers,  the cell line for expression and other conditions were optimized 






















Figure 4-1 Amino acid sequence of fusion form of Col108. Fusion Col108 contains a polyhistidine tag at N-
terminus (shown in brown colored text; followed by thioredoxin (shown in black colored text) and thrombin cleavage 
site (shown in pink colored text) linking His-tagged thioredoxin to Col108 sequence. A foldon domain is present at 
the C-terminal of sequence (shown in bold black colored text). The sequence of Col108 includes two Cys-Knots at 
both N-and C-terminal (Aqua colored text); three repeating units i.e.‘Col domain’ of 108 residues (shown in red, 
green and blue colored text). 
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4.2 Methods  
4.2.1 Expression and cell lysis 
A plasmid containing recombinant Col108 gene was transformed into bacterial expression 
strains. The expression includes the following steps. In the first inoculation, the 10mL culture 
containing antibiotic ampicillin (10µL of 50mg/mL stock solution) (Amp+) was incubated 
overnight in the shaker set at 200 rpm at 37°C. The next day, the 10mL culture was inoculated into 
1L ampicillin-containing LB media (1 mL of 50mg/mL stock solution, AMP+ LB media). The 
growth was monitored by determining the optical density of the culture at 600nm using DU800 
spectrophotometer. Once the optical density reached a value between 0.4-0.6,  100µL of 1M 
isopropyl-β-D-thiogalactoside (to a final concentration of 0.1mM IPTG) was added to induce the 
expression of Col108, and the culture was grown in the shaker at 300rpm, at 25°C for overnight 
(~16-18 hours)  
In the next step, the cells of a 1-liter liquid culture were centrifuged at 2000rpm for 20 minutes 
at 4°C (Beckman Coulter centrifuge with a rotor the JA-12 conical rotor, serial #03U1169). The 
supernatant media was removed, and the collected cell pellet was transferred into a 50mL 
disposable centrifuge tube. The cells were suspended in 20mL of chilled phosphate wash/extract 
buffer (50mM Na2HPO4, 150mM NaCl buffer, pH 8.0); 1mL of 20mg/mL of freshly prepared 
lysozyme solution was added to dissolve the cell wall. Sonication was used to lyse the cell 
(Vibracell, three 60 second pulses, machine output 3, duty cycle 30%, microtip limit 4). The cell 
lysate was kept on the ice whenever possible. To prevent the proteolysis of Col108, 0.5mL of 
freshly made protease inhibitor solution (0.2M PhenylMethylSulfonyl Fluoride (PMSF) in dry 
ethanol) was added after completion of sonication to a final concentration of 0.1mM of PMSF. 
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The cell lysate was centrifuged at 5000 rpm for 30 minutes at 4°C using a JA-12 conical rotor, 
serial #03U1169 to separate the fusion Col108 containing supernatant from lysed cell debris. 
 4.2.2 Purification of His-tagged fusion protein using His-affinity column 
The polyhistidine tag, consisting of six His- residues (His)6 on the N-terminus of the 
protein,  enables the purification of the recombinant peptide Col108, using widely employed, 
immobilized metal-affinity chromatography (IMAC) with commercially available Ni2+-affinity 
resin (Qiagen, Cat No./Id: 30310). The resin has nickel-nitrilotriacetic acid (Ni2+-NTA) matrix 
coupled to supporting matrix of Agarose. The transition metal ion (Ni2+) forms a coordinate bond 
with electron donor groups available on histidine residues’ imidazole rings. The presence of 
polyhistidine sequences, i.e. consecutive histidine residues, ensures efficient retention of tagged 
protein on the column of Ni2+-NTA resin. The purification was performed under native conditions 
following protocols suggested by Qiagen106. The wash/extract buffer is a pH 8 phosphate buffer 
with no imidazole (50mM Na2HPO4, 150mM NaCl).  
The resin was prepared by transferring 2mL of well suspended Ni2+-NTA metal affinity resin 
slurry into a 50mL disposable centrifuge tube and spun down in the centrifuge (Eppendorf 
centrifuge 5430R, F-35-6-30, CE 01167) at 2000 rpm for 5 minutes. The supernatant was removed, 
and the resin was resuspended in 10 mL of wash/extract buffer. The re-suspended resin was 
centrifuged again at 2000 rpm at 4°C and supernatant was removed. This step was repeated one 
more time to ensure the saturation of the resin with the wash/extract buffer.  
The resin was then mixed with the cell lysate containing the fusion Col108, sealed with 
parafilm and kept on the shaker in at 4°C for 3 hours for the His-tag to bind to the resin. After 
binding. The suspension was transferred into a clean gravity flow column which was rinsed with 
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10mL of Wash/extract buffer. The resin was left to settle in the column, and the supernatant was 
allowed to flow through and was collected in a 50 mL disposable centrifuge tube and labeled as a 
non-binding (NB).   
The resin bed in the column was then washed with 20 mL of wash/extract buffer containing 
10mM imidazole and collected as wash 1 (W1). The resin bed was again washed with 20mL of 
Wash/extract buffer containing 50mM imidazole and collected as wash 2 (W2).  
The fusion Col108 was finally eluted in fractions of 1mL with 10-12mL of wash/extract buffer 
containing 300mM Imidazole. The collected samples and fractions were analyzed using SDS-
PAGE on a 12% acrylamide gel. The molecular weight of protein was compared to high range and 
low range protein molecular weight markers. The bands in high range molecular weight 
marker(Sigma-Aldrich, Cat# S8320) corresponds to 200kDa, 116 kDa, 97kDa, 66kDa, 
55kDa,45kDa, 36kDa (top to bottom). The bands in low range molecular weight marker (Sigma-
Aldrich Cat# M3913) correspond to 66kDa, 45kDa, 29kDa, 24kDa, 20kDa, 14.2kDa (top to 
bottom). 
 The fractions showing a significant amount of protein were pooled and dialyzed against a 
phosphate wash/extract buffer to remove imidazole. The dialysis was carried out in the refrigerator 
for one day, with one change after 4-6 hour. The ratio of the protein sample (in mL) and dialysis 
buffer was 1:100.  
The Tris wash/extract buffer (pH 7) was also used in place of the phosphate wash/extract 
buffer. The Tris buffer has 50mM Tris, and pH of Tris buffer was adjusted to be 7, the 
concentration of NaCl was kept same as that of the Phosphate wash/extract buffer i.e. 150mM. 
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The Tris buffer was prepared with different concentrations of imidazole: 0mM, 10mM, 50mM, 
and 300mM.  
4.2.3 Thrombin cleavage. 
The powder form of human Thrombin enzyme was purchased from Thermo Fisher (cat 
number); each vial contains 120.4 NIH units of the enzyme, and each NIH unit equals to 0.324µg 
of the enzyme (120.4 NIH=39µg). The enzyme was dissolved in 100µL of 50mM Tris, 150mM 
NaCl (pH 7) buffer. Based on the instruction manual the enzyme is effective in a 1:500 enzyme to 
protein ratio, i.e. one vial of human thrombin enzyme powder can cleave ~19mg of protein.  
The samples of fusion-Col108 after Ni2+-affinity column were estimated to be ~ 2.6mg/mL 
concentration. The concentration of protein in the sample was estimated by measuring absorbance 
at 280nm using Beckman Coulter DU800 spectrophotometer with extinction coefficients of 
1mg/mL=0.232AU. The extinction coefficient was calculated by using ExPaSy ProtParam tool107. 
To optimize the thrombin enzyme to fusion protein ratio, as well as the optimal temperature and 
incubation time conditions for removal of His-tagged thioredoxin from Col108, in five Eppendorf 
tubes each containing 20 µL of peptide sample and 4µL, 1µL, 0.1 µL, 0.01 µL and 0.001 µL of 
enzyme solution were added, respectively, and incubated for one (18-20 hours) and two overnights 
(36-40 hours) at 4°C or at room temperature. The amount of the fusion protein in each of the 
sample solutions was ~52µg; the amount of thrombin are, respectively, 1.56µg (4µL), 0.39µg 
(1µL), 39ng (0.1µL), 3.9ng (0.01µL) and 0.39ng (0.001µL). The respective enzyme to protein 
ratio for each sample are calculated to be 1:33, 1:133, 1:1,333, 1: 13,333 and 1:133,333.  
In another trial, samples were prepared with 1µL (0.39µg), 2µL (0.78µg), or 3µL (1.17µg) 
of the enzyme added to 10µL of protein sample (26µg) and incubated for one overnight (~18-20 
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hours) at 4°C. The ratio of thrombin to the fusion protein of these samples are, respectively: 1:67, 
1:33 and 1:22. The SDS-PAGE analysis was used to study the results of thrombin cleavage. 
4.2.4 Separation of His-tagged thioredoxin from Col108 using HPLC 
The Col108, human thrombin enzyme, and the His-tagged thioredoxin-containing mixture 
solution were run on high-performance liquid chromatography (HPLC - Beckmann Coulter 
System Gold 126 solvent module,  detector 168 , SC100 fraction collector running 32 Karat 7.0 
software) with reverse phase C8 analytical column (Vydac, Cat# 208TP52) first. 
For analytical analysis, 20µL of fusion Col108 solution; human thrombin enzyme solution, 
and Col108 solution after thrombin cleavage were run on the analytical column separately with a 
flow rate of 0.2mL/minute. The analytical program measured the acetonitrile gradient, which 
increased linearly from 5% to 95% in 90 minutes starting from 5th minute onward till 90th minute 
with 1% increase per minute (Figure 4-2.1). 
For the preparative column, the Col108 sample was concentrated in a centriprep tube with 
a molecular weight cutoff membrane of 3kDa (Amicon Ultra centrifugal filter, Cat 
No.UFC900324) in a fixed angle rotor at 4000X g for 30 minutes at 4°C to reduce the sample 
volume to 2-5mL and run on reverse phase high-performance liquid chromatography (RP-HPLC). 
The concentrated Col108 mixture containing human thrombin enzyme and His-tagged thioredoxin 
was run on reverse phase C8 column (Vydac Cat #  208TP1010) with a time program graph where 
the initial acetonitrile gradient changes from 5% to 20% (15% increase) in 20 minutes, followed 
by 1% acetonitrile gradient increase per 2 minutes, changing the % acetonitrile gradient from 20% 
to 75% in a total time of 110 minutes with a flow rate of 2ml/minute (Figure 4-2.2). To decrease 
the total run time on the column from 110 minutes, and increase the elution time gap between 
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Col108 and Human thrombin enzyme, the time program graph was changed. In the modified 
program, initial acetonitrile gradient change from 5% to 30% is done in 15 minutes followed by 
the gradient change from 30% to 45%  in 30 minutes (1% per two minutes) and from 45% to 70% 
in 25 minutes (1% per minute) as shown in Figure 4-2.3. 
In a preparative column run as shown by time program graph in Figure 4-2.2 and 4-2.3, 
40 elution fractions with each fraction volume to be 1.5mL were collected after the 21st and the 
22nd minute of the run, respectively. The presence of protein in collected fractions was confirmed 
















Figure 4-2.1. Time program graph used for analytical column representing % gradient acetonitrile. A linear 




Figure 4-2.2. Time program graph used for preparative column representing % gradient acetonitrile. Initial 
change of acetonitrile gradient from 5% to 20% in 20 minutes (1% increase per minute) followed by increase in 














Figure 4-2.3. Modified time program graph used for preparative column representing change in % gradient 
acetonitrile. Initial change of acetonitrile gradient from 5% to 30% in 15 minutes (~1.67 % increase in acetonitrile 
gradient per minute) followed by increase in acetonitrile gradient from 30% to 45% in 30 minutes (0.5% increase in 
acetonitrile gradient per minute), followed by increase in acetonitrile gradient from 45% to 70% in 25 minutes (1% 
increase in acetonitrile gradient per minute). 
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4.3 Results: The optimization of expression and purification. 
4.3.1 The effects of the expression strain and the wash/extract buffer on the purification of 
the His-tagged, fusion form Col108. 
In order to choose the optimum condition for the expression and purification of the His-tagged 
fusion form Col108, the Col108 was expressed using the two commonly used bacterial expression 
strains of pET32a(+) plasmid: the E. coli strain JM109 and the E. coli strain BL21(DE3); and the 
purification by Ni2+-affinity resin were carried out using two different kinds of wash/extract buffer: 
Tris buffer (pH 7) and phosphate buffer (pH 8). The results are shown in Figures 4-3.1 to 4-3.5.  
The results in Fig 4-3.1 show the typical purification outcome.  The protein was expressed in 
JM109 cell. The fusion protein can be purified in either the monomer form (the predominant form, 
the red box, lanes 9-14) or the trimer form (the orange box, lanes 10-11). The His-tagged Col108 
can be seen only in the supernatant (lane 2) but not in the cell pellet (lane 3). The streaks in both 
lanes are often associated with the precipitation of protein and/or the concentration of the protein 
was too high. It was concluded that even the His-tagged fusion Col108 is a large protein, it is  
expressed in soluble form. The fusion form of Col108 was first purified using Ni2+-affinity resin. 
In this particular trial, some protein is present in non-bound (lane 5) but wash 1 and wash 2 (lane 
6 & 7) did not show any traces of fusion Col108, indicating the binding with Ni2+-NTA resin was 
effective. Fusion Col108 was eluted with 300mM Imidazole in phosphate wash/extract buffer. It 
was clear that eluted fractions contain the monomer (lanes 9-14) and the trimer form (lanes 10-12) 
of the protein. Several strong bands were observed in the low molecular weight range (the black 
box, lane 10-13). The identification of these bands was not made, but it was assumed that these 
bands were non-specifically bound proteins. Non-specific binding was a common drawback of 
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Ni2+-NTA resin. Alternatively, these bands could be fragments of the His-tagged Col108 due to 








Figure 4-3.1. Expression of His-tagged Col108 in JM109. Lanes 1 and 7 are, respectively, the 
high range and the low range protein markers. Lanes 2 and 3 are the samples of the supernatant 
and the cell pellet, respectively; lane 4is non-bound, lanes 5 and 6 are wash 1 and wash 2, 
respectively; lanes 8-14 the elution 1-7 (collected with a volume of 1 mL each).  Blue, purple, 
yellow and red boxes highlight the band of the monomer form of Col108 (molecular weight ~52 
kDa); orange box highlight the trimer form (molecular weight ~156 kDa). The bands in the black 




Once certain that His-tagged Col108 can be expressed in a bacterial expression system, 
efforts were directed towards improving the purification conditions by comparing different 
wash/extract buffers and different E Coli expressions strains. 
After expressed in JM109, the His-tagged Col108 were purified using two different buffers, 
and the results are as shown in Figures 4-3.2 and 4-3.3.  In Figure 4-3.2, no His-tagged Col108, 
monomer or trimer form, was seen in the cell pellet using Tris (pH 7) wash/extract buffer (lane 2) 
pointing towards the solubility of fusion Col108 and a complete breakdown of the E.coli cells. The 
cell pellet using phosphate (pH 8) buffer showed the presence of trimer form of the protein (orange 
box, lane 3); the monomer of fusion Col108 was not clear due to smearing (red box, lane 3). The 
presence of trimer in cell pellet sample could be due to the incomplete breakdown of cells during 
sonication step of purification. Further, viewing lanes 4 and 5, no band corresponding to molecular 
weight of fusion Col108 monomer or trimer was seen in the non-binding samples, whether using 
Tris or Phosphate, indicating efficient binding of fusion Col108 present in a cell lysate to Ni2+-
NTA resin. In lane 5, many non-specific protein molecular weight bands were seen. Focusing more 
specifically on the area on lane 5 where fusion Col108 band for monomer was anticipated, it was 
unclear if monomer was present or not since there was a cluster of bands found in the specified 
area (the black box, lane 5). The presence of fusion Col108 monomer (the purple box, lanes 6 and 
7) was seen in the first wash using Tris (pH 7) or phosphate (pH 8) wash/extract buffers containing 
10mM imidazole Trace amount of protein were also seen in the second wash (yellow box, lane 8 
& 9). The elutions using Tris or Phosphate buffers were shown in lanes 11 – 14. The presence of 
fusion Col108 monomer in elutions 1 and 2 in phosphate (pH 8) buffer are shown in the green 
boxes (lanes 12 and 14). Some high molecular weight bands were also observed in lane 12, 13 and 
14 indicating the presence of dimers (pink box). Similarly, elutions collected in Tris wash/extract 
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buffer (pH 7) containing 300 mM imidazole ((lanes 11 and 13) showed the presence of fusion 
Col108 monomer (white boxes). 
Similarly, in Figure 4-3.3, elutions collected using Tris wash/extract buffer (pH 7) 
containing 300 mM imidazole (lanes 2, 4, 6, 8, 10, 12 & 14). The presence of Col108 monomer 
was shown in white boxes. And elutions collected using phosphate buffer with 300mM imidazole 
showed the presence of Col108 monomer (green boxes, lanes 3, 5, 7, 9, 11 & 13). Some bands in 
high molecular weight range were seen (shown in the pink box), indicating the presence of either 
dimer of fusion Col108. Also, some low molecular weight bands around 14kDa area were seen 
(the black box).  
Comparing the elution collections using Tris or phosphate wash/extract buffers, it was 
observed that bands representing fusion Col108 monomer in tris buffer were much thicker. This 
difference is especially obvious in Fig 4-2B. We, therefore, decided to change the wash/extract 


















Figure 4-3.2 Effects of wash/extract buffer on the purification of His-tagged Col108 expressed in JM109. 
The His-tagged proteins were purified using Tris (pH 7) buffer (Lanes 2, 4, 6, 8, 11 & 13) and phosphate (pH 8) 
wash/extract buffer (Lanes 3, 5, 7, 9, 12 & 14). Lanes 2 and 3 are cell pellet, Lanes 4 and 5 are the non-binding, 
lanes 6 and 7 are wash 1, lanes 8 and 9 are the wash 2, lanes 11 &12 are the elution 1, lanes 13 &14 and the elution 
2. Lanes 1 and 10 are, respectively the high range and the low range protein marker. The orange, yellow purple, 
white and green boxes highlight the monomer form of His-tagged Col108, the magenta box identifies the higher 














Figure 4-3.3 (continuing from Fig. 4-3.2) Elution 3-9 are in lanes 2 & 3 – lanes 14 &15; where samples in 
lanes 2, 4, 6, 8, 10, 12 and 14 are eluted using Tris buffer containing 300 mM imidazole, and samples in 
lanes 3, 5, 7, 9, 11, 13 and 15 are eluted using phosphate buffer (pH 8) containing 300 mM imidazole. The 
white and green boxes highlight the monomer form of His-tagged Col108, the magenta box highlight the 
oligomers, and the black box the unidentified species. 
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Also, after expression of fusion form of Col108 in BL21(DE3), purification steps were 
optimized for Tris and phosphate buffers. The results are shown in Figure 4-3.4 and 4-3.5. In 
Figure 4-3.4,  No presence of fusion Col108 monomer or trimer in cell pellet for tris buffer was 
seen (lane 2), fusion form of Col108 was present only in cell lysate (monomer: the dark red and 
trimer: the pink box, lane 4). The non-bound sample appeared to contain a very faint band at the 
same molecular weight as fusion Col108 monomer ( light blue box, lane 6). The first wash sample 
showed the presence of non-specific proteins bound to the column to be washed out with 10mM 
imidazole (lane 8). But, it was unclear if 10mM imidazole eluted any fusion Col108 monomer 
from the column in the first wash.  A faint band was seen in the fusion form col108 monomer 
molecular weight range (the blue box, lane 8). The second wash of column sample pointed clearly 
towards no loss or elution of bound fusion form Col108 in the second wash (the orange box, lane 
10). The presence of fusion form of Col108 monomer was seen in first eluted fraction (the tan box, 
lane 12).  Lane 3 showed cell pellet sample in phosphate wash/extract buffer (pH 8).The presence 
of fusion form of Col108 monomer indicated towards improper lysis of cells during sonication 
(the yellow box). The sample for supernatant/cell lysate indicated the presence of fusion Col108 
monomer and trimer (the green and the light green box respectively, lane 5). The non-bound 
sample collected after settling the resin in matrix column in lane 7 showed the clear presence of 
fusion Col108 monomer (the white box) and trimer (the purple box). The first wash sample showed 
the presence of non-specific proteins bound to the column to be washed out with 10mM imidazole( 
lane 9). A faint band in the fusion col108 monomer molecular weight range was seen (the blue 
box). The second wash sample showed no presence of fusion Col08 (the orange box, lane11).  SDS 
sample of first elution fraction collected in phosphate buffer showed the very faint band at an 
expected molecular weight range of fusion Col108 monomer (the tan box, lane 13). 
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In Figure 4-3.5, the presence of fusion form of Col108 monomer (the white boxes, Lanes 
1,3 5,7,9 & 11) and fusion form of the Col108 trimer (the red boxes, lanes 3,5 &7) in Tris 
purification was very clear. Lanes 2, 4, 6, 8, 10 and 12 showed the presence of fusion Col108 
monomer (the green boxes) and lanes 4 and 6 showed the presence of a faint band corresponding 
to fusion Col108 trimer (the yellow boxes) in phosphate purification. Also, few bands were 
observed between fusion Col108 monomer and trimer, which could be due to either degradation 
of Col108 fusion trimer or formation of dimers of Col108 from fusion monomers. It could also be 
possible that some non-specific, high molecular weight proteins with the same affinity for Ni2+-
NTA resin as fusion Col108 got eluted with 300mM imidazole (the pink box). Some low molecular 
weight bands were seen (the black box).  The identity of these bands was not clear. These could 
be either some non-specific proteins or degraded fusion Col108. Based on the comparative 
analysis, both bandwidth and intensity indicated the presence of more protein in purification with 
Tris wash/extract buffer compared to phosphate. Also, binding to Ni2+-NTA resin was more 
effective when we used Tris buffer as we did not lose any Col108 fusion monomer and trimer in 
non-bound cell lysate and washes. So we decided to switch our buffer during purification from 





















Figure 4-3.4 Effects of wash/extract buffer on the purification of His-tagged Col108 expressed in BL21. 
The His-tagged proteins were purified using Tris (pH 7) buffer (Lanes 2, 4, 6, 8, 10 & 12) and phosphate (pH 8) 
wash/extract buffer (Lanes 3, 5, 7, 9, 11 & 13). Lanes 2 and 3 are cell pellet, Lanes 4 and 5 are the non-binding, 
lanes 6 and 7 are wash 1, lanes 8 and 9 are the wash 2, lanes 11 &12 are the elution 1, lanes 13 &14 and the 
elution 2. Lanes 1 and 14 are, respectively the low range and the high range protein marker. The red, yellow, 
dark red, dark green, light blue, white, blue, orange and tan boxes highlight the monomer form of His-tagged 
















Figure 4-3.5 (continuing from Fig. 4-3.4) Elution 2-7 are in lanes 1 & 2 – lanes 11 &12; where samples in lanes 1, 3, 5, 7, 9 
& 11 are eluted using Tris buffer containing 300 mM imidazole, and samples in lanes 2, 4, 6, 8, 10 & 12 are eluted using 
phosphate buffer (pH 8) containing 300 mM imidazole. Lanes 13 and 14 are respectively high and low range protein markers. 
The white and green boxes highlight the monomer form of His-tagged Col108; the red and yellow boxes highlight the trimer 
form of His-tagged Col108; the magenta box highlights the oligomers; and the black box highlights the unidentified species. 
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4.3.2 Optimized Thrombin cleavage 
 Thrombin cleavage was used to remove His-tagged thioredoxin from fusion Col108 
(Figure 4-4). Several trials were conducted to find the optimum thrombin enzyme to fusion protein 
to ensure complete removal of His-tagged thioredoxin. 
The respective enzyme to fusion protein ratio of 1:33, 1:133, 1:1,333, 1: 13,333 and 
1:133,333 were used, and the incubation time were between one overnight (18-20 hours) and two 
overnight (36-40 hours). In Figure 4-5.1, lanes 1 and 2 showed efficient thrombin cleavage with 
an enzyme to protein ratio of 1:33 as indicated by the presence of a band corresponding to Col108 
monomer (the tan box). The Col108 trimer was present (the blue box, lane 1).  Col108 monomer 
and trimer bands were easily identified by comparing to, respectively, the bands of fusion Col108 
monomer (lanes 11 and 12, light blue box) and trimer (shown in aqua box) and also comparing to 
the protein molecular weight marker (lane 13) The sample in lane 1 was incubated at 4°C for one 
overnight (~18-20 hours), in lane 2 at room temperature for one overnight. The bands in lane 2 
appeared to shift slightly upward, but still showed the complete removal of His-tagged thioredoxin. 
The band for the Col108 is clearly visible, and the band for the fusion protein disappeared. There 
was no Col108 trimer in Lane 2. The intensity of the bands was lighter in lane 2 compared to lane 
1, which could be caused by the degradation/ precipitation of Col108 due to incubation at room 
temperature.  
 Samples with an enzyme to protein ratio of 1:133 after one overnight incubation at 4°C or 
room temperature were observed (lane 3 and 4 respectively). The sample incubated at 4°C showed 
the presence of Col108 monomer and trimer (the red and the dark red box), but the sample 
incubated at room temperature showed the only presence of Col108 monomer (dark red box).The 
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intensity of Col108 monomer band in lane 4 was lesser compared to the respective band in lane 3 
(the dark red box). 
 Lanes 5 and 6 showed the samples with an enzyme to protein ratio of 1:1333 after 
overnight incubation at 4°C or at room temperature, respectively At 4°C, the incomplete thrombin 
cleavage due to the presence of Col108 fusion monomer (the black box). A band corresponding to 
the Col108 monomer (the orange box) and a very faint band corresponding to the trimer (the yellow 
box) was observed. Lane 6 showed completion of thrombin cleavage at room temperature as no 
fusion Col108 was observed on the SDS-PAGE; the Col108 monomer band was clearly seen (in 
the orange box). 
 The fusion form of Col108 monomer was observable in samples with the enzyme to 
protein ratio of 1: 13333 (lanes 7 and 8, the dark green box) or 1:133333 (lanes 9 and 10 in dark 
pink box). The trimer band of the fusion form of Col108were also visible in lane 7 and 8, 9 and 10 
(light green box and light pink box respectively). It is clear that one overnight incubation at these 
low concentrations of the enzyme was ineffective at 4°C or room temperature. These findings were 
expected since the recommended range of enzyme to protein ratio for efficient thrombin cleavage 
was 1:500, much higher than those used in lanes 7-10.  
We also examined the digestion after prolonged incubation – two overnights at room 
temperature or 4°C, all together for about 36-40 hours. SDS-PAGE samples were prepared, and 
the results were shown in Figure 4-5.2. The findings were similar to those after 18hr incubation. 
The enzyme digestion was complete at ratios 1:33 (lanes 4-5) and 1:133 (lanes 6-7) after 48 hours 
incubation at either room temperature (lanes 4 and 6) or 4° C (lanes 5 and 7). The monomer band 
of the Col108 monomer (the orange box in lanes 4-5 and the dark red box in lanes 6 and 7) and 
trimer band (the blue box in lanes 4-5 and red box in lane 7) are clearly visible. The sample with 
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an enzyme to protein ratio of 1:1333 incubated at 4°C that the quantity of enzyme in protein 
solution was not effective for efficient thrombin cleavage (lane 9). We observed Col108 fusion 
monomer (shown in the black box). While no fusion protein was observed in samples with the 
same enzyme to protein ratio but incubated at room temperature (lane 8), the bands were so faint 
it is difficult to draw the conclusion. In fact, the bands of samples incubated at room temperature 
were all significantly lighter in intensity comparing to those at 4°C, even the samples without any 
addition of Thrombin (lane 2), indicating the potential loss of protein to degradation at this elevated 
temperature.     
Once again Samples with an enzyme to protein ratio of 1: 13333 (lanes 10-11) and 
1:133333 (lanes 12-13) confirmed that the quantity of enzyme in these samples is so small that 
even a longer incubation time was not leading to the removal of His-tagged thioredoxin from the 
fusion protein. Only fusion form of Col108 monomers and trimers were observed (the green and 
the light green boxes in lanes 10-11, the pink and the light pink boxes in lanes 12-13).   
To further define the most effective and also economical level of enzymatic cleavage, we 
studied the effects of enzyme: protein ratio of 1:67, 1:33 and 1:22 incubated for one overnight at 
4°C. While 1:133 show complete thrombin cleavage in Figure 4-5.1 and 4-5.2, but occasionally 
we did observe a faint band of the fusion protein. Therefore, we decided not to carry out the 
reaction with enzyme: protein ratio of 1:133 or lesser enzyme. The results are shown in Figure 4-
5.3. A complete digestion in samples with an enzyme to protein ratio of 1:67, 1:33 and 1: 22 was 
clearly seen in lanes 3, 4 and 5, respectively. The Col108 monomer was shown in light blue, yellow 
and pink box respectively. The His-tagged thioredoxin was also clearly seen in lanes 3-5 (the black 
box). A band can be identified as that of the thrombin enzyme (Lane 1). This Thrombin band was 
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visible in lane 5 (bright red box) and in other samples having a relatively low concentration of the 





















Figure 4-5.1 Optimization of thrombin cleavage after overnight (18 hours) incubation. The enzyme:protein ratio 
is 1:33 for lanes 1 and 2, 1:133 for lanes 3 and 4, 1: 1333 for lanes 5 and 6, and 1:133,333 for lanes 9 and 10. Lanes 
11 and 12 are samples of the fusion protein prior to the addition of thrombin. Samples of lanes 1, 3, 5, 7, 9 and 11 
were incubated at 4°C during the digestion, and those in lanes 2, 4, 6, 8, 10 and 12 were kept at room temperature 










Figure 4-5.2 optimization of the thrombin cleavage after two overnights incubation (~ 40 hours). Lanes 2 and 3 are 
samples of the fusion protein prior to the addition of thrombin. The enzyme:protein ratio are 1:33 for lanes 4 and 5, 1:133 for 
lanes 6 and 7, 1:1,333 for lanes 8 and 9, 1:13,333 for lanes 10 and 11 and 1:133,333 for lanes 12 and 13. The samples in lanes 
2, 4, 6, 8, 10 and 12 were incubated at room temperature (~ 28°C), and those in lanes 3, 5. 7. 9. 11 and 13 were incubated at 
4°C. Lane 1 is the low range protein marker, and lane 15 is the high range protein marker. Lane 14 is another sample prior to 





Figure 4-5.3. Optimization for enzyme:protein (E:P) ratio for thrombin cleavage 
using lyophilized human thrombin enzyme; lane 1 showing human thrombin 
enzyme; lane 2 showing fusion Col108; lane 3 showing E:P ratio of 1:67; lane 4 
showing E:P ratio of 1:33; lane 5 showing E:P ratio of 1:22; lane 6 showing low range 
protein molecular weight marker (6,500- 66,000 Da).samples in lanes 3-5 were 
incubated at 4°C for one overnight (~18 hours). 
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Even though the recommended enzyme/protein ratio is 1:500, after analyzing different 
thrombin cleavage set ups to find optimal conditions and ensure the complete removal of His-
tagged thioredoxin from Col108, we decided to use an enzyme: protein ratio of 1:66. We also 
determined that one overnight incubation (~18-20 hours) at 4°C is the optimal condition for 
thrombin cleavage. 
4.3.3 High-performance liquid chromatography as final purification step 
 After thrombin cleavage, the next and final step was a complete separation of Col108 
from His-tagged thioredoxin and human thrombin enzyme. We first did the analytical run 
separately on fusion Col108, human thrombin enzyme solution, and Col108. The analytical 
program was then scaled up for the preparative column. 
In the analytical run spectra shown for Fusion Col108 in Figure 4-6.1(i) showing 
absorbance spectrum at wavelength 214nm and 280nm; and (ii) showing absorbance spectrum at 
wavelength 280nm, we observed that fusion Col108 (His-tagged thioredoxin containing Col108) 
elutes at 62.5% acetonitrile gradient (~62nd minute - shown in the orange box).  
For human thrombin enzyme run on the same analytical column using the same time 
program graph (Figure 4-2A), we observed in Figure 4-6.2(i) showing absorbance spectrum at 
wavelength 214nm and 280nm; and (ii) showing absorbance spectrum at wavelength 280nm that 
human thrombin enzyme elutes at 53% acetonitrile (~53rd minute - shown in light blue box).  
Using the same time program graph for the Col108 sample after thrombin cleavage, i.e. 
sample containing Col108, human thrombin enzyme and His-tagged thioredoxin: the absorbance 
spectrum observed at wavelength 214nm and 280 nm as shown in Figure 4-6.3(i); and spectrum 
observed only at 280nm as shown in Figure 4-6.3(ii) showed that Col108 eluted at 46% 
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acetonitrile (~46th minute - shown in pink box in Figure 4-6.3(i) & (ii)),  human thrombin enzyme 
eluted at 53% acetonitrile (~53rd minute - shown in light blue box in Figure 4-6.3(i) & (ii)) and 
thioredoxin eluted at 62.5% acetonitrile gradient (~62nd minute), respectively (shown in orange 
box in Figure 4-6.3(i) & (ii)). 
For the preparative column after finding the acetonitrile % gradient for elution of Col108, 
human thrombin enzyme and His-tagged thioredoxin, we scaled up the program graph as shown 
in Figure 4-2.2 and 4-2.3, and observed the HPLC spectra showing Col108 eluting at 38% 
acetonitrile (~56th minute - shown in pink box), Human thrombin enzyme eluting at 44% 
acetonitrile (~70th minute - shown in light blue box) and thioredoxin eluting at 54% acetonitrile 
(~88th minute - shown in orange box) (Figure 4-7). But in the modified program, the Col 108 
elutes at ~32nd minute (38 % Acetonitrile), thrombin elutes at 45th minute (44% acetonitrile), and 





Figure 4-6.1 (i) HPLC spectra of Fusion Col108 at 214nm and 280nm; (ii) HPLC spectrum of Fusion Col108 at 
280nm; Fusion Col108 elutes at 60% to 65% acetonitrile (~ from 60 minutes to 65 minutes).Peak corresponding to 




Figure 4-6.2 (i) HPLC spectra of Thrombin enzyme at 214nm and 280nm; (ii) HPLC spectrum of Thrombin 
enzyme at 280nm;  Human thrombin enzyme on the spectrum elutes at 53% acetonitrile gradient (~53 minutes). Peak 




Figure 4-6.3 (i) HPLC spectra of Col108 after thrombin cleavage at 214nm and 280nm; (ii) HPLC spectrum of 
Col108 after thrombin cleavage at 280nm;  Col108 elutes at 46% acetonitrile gradient (~46 minute); human 
thrombin enzyme elutes at 53% acetonitrile gradient (~53 minutes) and thioredoxin elutes at 63.5% acetonitrile 
gradient (~63.5 minute). Peak corresponding to Col108 protein on the spectrum is shown in a pink box. A peak 
corresponding to human thrombin enzyme on the spectrum is shown in a light blue box. A peak corresponding to His-






Figure 4-7. HPLC spectra for Col108 after thrombin cleavage at 280nm. Col108 elutes at 38% acetonitrile (56th 
minute); Human Thrombin enzyme elutes at 44% (70th minute) and His-tagged thioredoxin elutes at 54% acetonitrile 
(88th minute). A Peak corresponding to Col108 protein on the spectrum is shown in a pink box. A peak corresponding 
to human thrombin enzyme on the spectrum is shown in a light blue box. A peak corresponding to His-tagged 





Figure 4-8. HPLC spectra for Col108 after thrombin cleavage at 280nm. Col108 elutes at 38% acetonitrile (32nd 
minute); Human Thrombin enzyme elutes at 44% (45th minute) and His-tagged thioredoxin elutes at 54% acetonitrile 
(61stth minute). Peak corresponding to Col108 protein on the spectrum is shown in a pink box. A peak corresponding 
to human thrombin enzyme on the spectrum is shown in a light blue box. A peak corresponding to His-tagged 






Figure 4-9. A 12% SDS PAGE confirming the presence of Col108 peptide in the collected HPLC fractions as 




From these studies, we learned that the bacterial strain has little effects on the expression. 
Both JM109 and BL21 were used for the subsequent experiments. On the other hand, the Tris (pH 
7) clearly show less non-specific binding to the resin, less loss of protein during binding; therefore, 
it became our choice of buffer.  The optimal conditions of thrombin cleavage were found to be one 
overnight incubation at 4°C with thrombin enzyme to fusion protein ratio of 1:66. One crucial step 
before thrombin cleavage was to dialyze the fusion protein sample to remove imidazole from the 
solution. The thrombin was usually added after the first change of dialysis buffer (the change 
usually take place after ~ 4 hr dialysis). The HPLC appeared to be an effective method to separate 
Col108 from thrombin and His-tagged thioredoxin. The SDS-PAGE confirmed that final Col108 













The folding and the thermal stability of Col108 peptide 
5.1 Introduction 
The Col108 peptide is unique in the sense that it is significantly longer compared to 
synthetic collagen-like peptides studied so far. This peptide has a total of 417 amino acid residues, 
out of which 378 are in a non-interrupted collagen-like Gly-X-Y sequence. Additionally, it has a 
built-in sequence periodicity arising from three pseudo-identical sequence units placed in tandem; 
each unit contains ~123 amino acid residues (Figure 3-1). After successful purification of Col108, 
the next goal was to ensure that the peptide folded into a triple helix and is stable under the 
experimental conditions for further studies.  
5.2 Methods 
5.2.1 Preparing Col108 solutions 
 Lyophilized Col108 powder was dissolved in a 5mM acetic acid (HAc, pH 4) solution to a 
concentration of ~1mg/mL. The concentration was determined by measuring absorbance at a 
280nm wavelength with an extinction coefficient of 0.232AU (1mg/mL). The extinction 
coefficient was calculated by the ExPaSy Protparam tool. The samples were equilibrated in the 
refrigerator for ~10 days to ensure triple helix formation. The conformation was checked by the 
wavelength scan using circular dichroism (CD) spectroscopy. Samples for the wavelength scan 
were prepared by diluting to a concentration of 0.2mg/mL. The wavelength scans were also 
performed on Col108 fibrils in fibril-forming buffer (2.5mM HAc, 30mM TES, 30mM Na2HPO4 
and 67.5mM NaCl, pH 7.4). The concentration of the samples were adjusted to 0.2mg/mL from 
0.5mg/mL. The samples used for thermal stability studies were prepared at a concentration of 
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1mg/mL or 0.5mg/mL in 5mM HAc and fibril-forming buffer, respectively. The samples were 
further equilibrated for ~2-4 days after each dilution before any CD data were taken. Once folded, 
the conformation was stable. The spectra of wavelength scans are highly reproducible even after 
extended storage at 0.2 mg/mL in the refrigerator. 
5.2.2 Conformation Studies 
 The triple helix conformation of Col108 was determined using a circular dichroism 
spectrometer (AVIV Biomedical, Model 202-01). The wavelength scans were conducted at 4°C 
between wavelength 190 and 300nm, with the 1nm interval. Hellma quartz CD cuvettes (1mm 
pathlength) were used. CD wavelength data was normalized to a mean residue ellipticity (MRE)., 
the molecular weight of 38.156 kDa and the number of residues (417)  per single chain of Col108 
were used.  
5.2.3 Thermal studies 
 The thermal unfolding was studied to determine the stability of Col108 in different buffers. 
The temperature melt experiment was conducted by heating the sample from 4°C to 65°C with an 
equilibration time of two minutes at each temperature; the estimated average heating rate is 
0.3°C/minute, and the unfolding of Col108 was monitored at 225nm. The data was normalized to 
the fraction of folded peptides, as described in Xu et al.108  
5.3 Results  
5.3.1 Conformation of peptide Col108 
 Col108 adopts a triple helical conformation at 4°C in 5mM HAc (pH 4) as shown by the 
characteristic CD spectra with a positive peak at 225nm and a low, negative peak at 197nm (Figure 
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5-1). Spectra was also observed in pH 7.4 buffer. The ratio of positive to negative peak intensity, 
known as the ‘Rpn’ of Col108 is ~0.067. This Rpn is lower compared to the Rpn value observed 
for (POG)n 
109-110 but is in good agreement with that of the peptide (GPP)10, (GPP)10-foldon, and 

























Figure 5-1 Circular dichroism spectra of Col108 at 0.2mg/mL and 4°C in 5mM acetic acid (pH 4; open blue circles) and 
in fibril forming buffer (pH 7.4; open red triangles).  
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5.3.2 Thermal stability of peptide Col108 
 Col108 triple helix is quite stable with a melting temperature of ~41°C in pH 4 buffer and 
pH 7.4 buffer (Figure 5-2).  
5.4 Conclusion 
 Despite lacking hydroxyproline at Y-position, Col108 folds into a stable triple helix with 
a Tm value of 41°C. The higher than usual content of charged residues in the Col domain, the 
presence of Cys-knots at both N- and C-termini, the regular inserts of (GPP)4 and the foldon 
domain could be the sequence design features  of Col108 that are contributing to its thermal 
stability.  The Col108 exists as triple helices in pH 4 buffer, but form mini-fibrils in the fibril-
forming buffer as will be described in the next chapter. However, the thermal stability is the same 

























Figure 5-2 Temperature melt curve of Col108 at 1.2mg/mL and 4°C in 5mM acetic acid (pH 4; open blue circles) 




The self-assembled Col108 mini-fibrils* 
*This chapter is adapted from manuscript Kaur et al.115 
6.1 Introduction 
Collagen is studied for its versatility and involvement in a wide range of cellular functions 
during tissue development. This versatility of collagen made it: a successful scaffold to be studied 
extensively for biomedical applications like tissue engineering116-117 and in vitro substrate for 
studying phenomena like cell differentiation118, adhesion119, and migration120. Also, collagen has 
been extensively studied to understand the role of mutations in structure and/or synthesis of this 
protein leading to diseases such as Osteogenesis imperfecta and Ehlers-Danlos syndrome121-122. 
To understand the structure, functions, and interactions involved in the self-assembly of this 
extensively abundant protein in the body, self-assembling collagen-mimetic peptides that model 
specific properties of collagen fibrils have been sought after by researchers. 
Many of the reported self-assembled collagen mimetic peptides have often relied on the 
introduction of chemical moieties at the ends of the triple helices. The self-assembled fibrils 
observed in these cases lacked the specific structural features of native collagen fibrils5, 7, 9, 47, 123-
125.  The one exception is the D-periodic microfibers formed by the self-assembly of a 36-resdiues 
synthetic collagen-mimetic peptide reported by Rele et al.3. The self-assembled microfibers 
revealed the banding pattern of 18nm which is larger than what is the anticipated end-to-end 
distance of 10-12nm predicted for a 36-residue long triple helix. Also, the microfibers were formed 
only after thermal annealing, i.e. unfolding of triple helices. So the underlying mechanisms of the 
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observed self-assembly were assumed to be significantly different from the staggered lateral 
packing of the triple helices as observed in native collagen fibrils.  
In brief, it can be stated that even though functional collagen-mimetic peptides have been 
developed in the past, such studies rely only on short peptides which are usually 30-35 residue 
long and also, many of these bottom-up assemblies employ techniques like chemical cross-linking, 
native chemical ligation and thermal annealing. Therefore, a major limitation of such systems is 
that it is very difficult to ascribe a direct association between designed and native when it comes 
to defining the molecular mechanisms involved.  
Therefore, our goal was to develop a collagen-like peptide that does not involve the 
external chemical moieties but includes the features which are inherent to the native collagen. We 
specifically focused on the sequence periodicity and engaged it in our design to accomplish a two-
fold goal: to develop a scaffold which not only mimics the native collagen fibril under the defined 
optimal condition of self-assembly but also gives insight into the underlying molecular 
mechanisms of self-assembly. The significance of this system is that it can be used as a potential 
functional scaffold in tissue engineering and regenerative medicine. 
After triple helical conformation of Col18 peptide had been confirmed by CD 
spectroscopy, our next goal was to study if Col108 self-assembles into a higher-order assembly, 
which bears any resemblance to native collagen fibrils.  
6.2 Methods 
6.2.1 Fibril formation of Col108  
 The fibrillogenesis experiment was set up using 1mg/mL of Col108 in 5mM HAc (pH 4) 
kept at 4°C. The sample was then mixed in 1:1 volume ratio with double strength neutralization 
91 
 
buffer (2X buffer: 30mM TES, 30mM Na2HPO4, 67.5mM NaCl; pH 7.4). The final concentration 
of Col108 was 0.5mg/mL in the fibril-forming buffer, which has a composition of 2.5mM HAc, 
30mM TES, 30mM Na2HPO4 and 67.5mM NaCl composition (pH 7.4). The neutralized Col108 
solution was incubated at 37°C or 26°C. The pH was determined in a separate test trial using fibril 
forming buffer, formed by mixing an equal volume of pH 4 HAc and pH 7.4 2X neutralization 
buffer.  
6.2.2 TEM characterization of Col108 mini-fibrils  
TEM grids of Col108 fibrils were prepared at 6 hours and 24 hours after fibrillogenesis 
initiation at 26°C or 37°C using 400 mesh Formvar-carbon coated copper grids. 3µL of incubated 
sample was allowed to sit on the grid for 100 seconds. The grids were rinsed with deionized water 
for 5 seconds and stained with 3µL of 1% sodium phosphotungstate for 100 seconds. The grids 
were rinsed again with deionized water for 5 seconds. The grids were air-dried before being 
examined under a Jeol 2100 electron microscope (Jeol Inc.). The collected images were analyzed 
using ImageJ software126.  
 The axial periodicity was determined by manually measuring the negatively stained images 
using a ruler on the original picture printout of the micrograph. Approximately, 40 such 
measurements from 4 separate TEM images (two from a sample after 6 hours of incubation at 
37°C and two from a sample after 24 hours of incubation at 37°C) were taken.  The periodicity of 
the mini-fibrils formed at 26°C was determined based on 11 such measurements taken from two 
separate TEM images after 6 hours of incubation. 
6.2.3 AFM characterization of Col108 mini-fibrils  
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 For tapping mode AFM imaging, samples were prepared on a freshly cleaved mica 
substrate. A 10µL volume of Col108 sample after overnight incubation was placed directly on the 
substrate. The sample was rinsed gently with deionized water after drying. AFM imaging of the 
substrate was carried out using NSC15/AlBS probes from Mikromasch in the tapping mode 
(spmtips, nominal radius ~8nm, force constant 40N/m and resonance frequency 325 kHz). All the 
imaging was carried out using a TM-AFM and scanner (Agilent 5500). Random locations of the 
sample were imaged. The image analysis and measurements were performed using WSxM 5.0 
software127. The axial periodicity was measured as the distances between the peaks of the phase 
retrace plots based on ~20 measurements.    
6.3 Results 
Upon incubation of Col108 in the fibril-forming buffer at 26°, or 37°C, the Col108 the the 
self-assembled aggregate were examined using TEM and AFM. The fibrils were examined after 6 
hours or 24-hours incubation at 26°C or 37°C.  Analytical ultracentrifugation study has indicated 
the self-associated aggregates are formed in solutions 115.   
6.3.1 The mini-fibrils of Col108 with ~35nm periodicity 
 Under TEM, the assembled aggregates of Col108 were observed to be fibrillary. The fibrils 
appear to have variation in diameter and length. Most fibrils after 6 hours of incubation are 400-
600nm long and have a diameter of about ~50nm (Figure 6.1-3). Fibrils formed after overnight 
incubation are longer (800nm -1µm) and have a diameter mostly in the range of 75nm with some 
having a width of 100nm (Figure 6-1 to 6-3). The exact length of some fibrils is difficult to 
determine because the ends of individual long mini-fibrils were difficult to discern. 
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 The most striking observation is the banding pattern on the fibrils under all the conditions 
examined, irrespective of variations in length and diameter. Under negative staining fibrils formed 
under different conditions, all showed a repeating banding pattern of a dark and light band repeats 
of ~~35nm; very similar to the D-period of 67nm of fibrillar collagen comprised of one dark and 
light band .The dark band in Col108 fibril is 25nm and light band is 10nm observed through the 
entire length of the fibril (Figure 6-1(i), 6-2(i), 6-3(i)B). The average value of axial periodicity of 
a mini-fibril formed at 37°C was determined to be 34.6nm. The mini-fibrils formed after 
incubation at 26°C have a similar average periodicity of 34.2nm. This ~35nm axial periodicity was 
named the “d-period” because of its comparable yet different features from the D-period of type I 
collagen fibril. The comparable banding features of collagen fibrils (ref) and Col108 fibrils led us 
to conclude that Col108 fibrils have a similar alternating gap and overlap regions as collagen, 
except the periodicity, is ~35nm.  
 The Col108 fibrils stained positively show different banding pattern under the same 
assembly for different TEM grids. (Figures 6-1(ii), 6-2(ii), 6-3(i)A and (ii)). The pattern can be 
characterized by three pairs of alternating thick and thin dark bands, intercalated with light bands 
along the length of one triple helix of Col108, which is ~120nm long. Unlike the negative staining, 
in a positive staining pattern, the dark bands represent the direct binding of heavy metal ions to the 
charged residues on the surface of fibrils. The banding pattern observed on the surface of Col108 
fibrils reflects the finer distribution of charged residues on the fibrils, and reflect an ordered 
arrangement of triple helices. Any random arrangement of triple helices with misaligned charged 
zones would result in an undefined distribution of charges regions on the surface of the mini-fibril, 
and will, therefore, lead to an undefined non-specific staining appearance. Our observations, on 
the contrary, were indicating a defined and specific positive staining pattern on mini-fibrils of 
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Col108 pointing towards a specific arrangement of triple helices of Col108. In this arrangement, 
there are three pairs of thick-thin dark bands every ~100- nm, which is the approximate length of 




Figure 6-1 The electron micrographs of Col108 mini-fibrils; (i)A-E, the negatively stained mini-fibrils (A-E); 
(ii)A-B, positively stained mini-fibrils. Samples are prepared from the neutralized Col108 solution incubating for 6 
hours at 37°C. Different measurements for d-period are shown in proportion to the scale bar are shown in all the 




Figure 6-2 The electron micrographs of Col108 mini-fibrils; (i)A-D, the negatively stained mini-fibrils (A-D); 
(ii)A-D, positively stained mini-fibrils. Samples are prepared from the neutralized Col108 solution incubating for 24 
hours at 37°C. Different measurements for d-period are shown in proportion to the scale bar are shown in all the 








Figure 6-3 The electron micrographs of Col108 mini-fibrils; (i)A-B, the positively stained mini-fibrils (A); the 
negatively stained mini-fibrils (B) Samples are prepared from the neutralized Col108 solution incubating for 6 hours 
at 26°C; (ii)A-B, positively stained mini-fibrils (A and B). Samples are prepared from the neutralized Col108 
solution incubating for 24 hours at 26°C. Different measurements for d-period are shown in proportion to the scale 
bar are shown in all the images. The scale bars are 200nm (i)-A and (ii)-A and B, 100nm in (ii)-B. Small fibrils 
matching the dimesions of a triple helix can be seen in the inset marked with arrows. 
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6.3.2 The d-periodicity of mini-fibrils of Col108 characterized by AFM 
 The d-period of ~~35nm observed in electron micrographs of Col108 fibrils was emulated 
nearly quantitatively by atomic force microscopy. The scanning image and the resulting contour 
profile for Col108 fibril samples after 24 hours of incubation at 37°C is shown in Figure 6-4. The 
mini-fibrils have similar morphological features to those seen under TEM. Irrespective of visible 
and bulky salt crystals on the scanned images, the unbranched and spindle-shaped fibrils of 800-
1000nm length and 50-75nm in diameter were seen. The scanning profile of the fibrils revealed a 
periodicity of approximately ~38nm based on the measurements of 20 mini-fibrils. The d-period, 
in this case, is more than that estimated from TEM images because of the low resolution of the 
AFM images. The clear boundaries of gap and overlap regions were difficult to follow due to salt 
deposits as well as the small features of  the d-period, itself. Also, the size of the gap/overlap, i.e. 
25nm/10nm pattern, is close to the detection limit of the tip used in this study. Nonetheless, the 



















Figure 6-4 AFM analysis of the Col108 mini-fibrils; A, The tapping mode topographic image of Col108 mini-
fibrils. Samples were incubated for 24 hours at 37°C. Inset A is the phase retrace image of a region marked in circle 
on topographic image. B. surface profile of the mini-fibril marked by a short bar on the inset. 
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6.4 A Model for Col108 mini fibrils: a sequence unit staggered, lateral self-assembly of triple 
helix  
6.4.1 The interaction curves 
Similar to collagen fibrils, the assumption was made that molecular recognition during self-
assembly of Col108 is mediated by the specific interactions of amino acid residues on the surface 
of the triple helices. These interactions can be translated directly from the amino acid sequence of 
the peptide, given the linear conformation of the triple helix.  
In order to understand observed banding pattern in the TEM images, stained either positive 
or negative, and the AFM images, we constructed the stability curve based on the interaction graph 
using the method used for natural collagen22. A computer program using in-house Perl script was 
created for this calculation, and the details of the calculation for Col108 is shown in Kaur et al115. 
Basically, this program compared two amino acid sequences of Col108. One sequence was used 
as a reference while the other was shifted with respect to the reference one residue at a time.  After 
each shift, the directly opposed amino acid and the immediately flanking neighbors in the two 
chains were compared. For each hydrophobic coupling and electrostatic interaction, a value of one 
was assigned, and the total interaction value was reported. Interaction values were normalized by 
the total number of possible interactions at each calculation cycle. Hydrophobic amino acids 
considered were Val, Met, Ile, Leu, Phe, and Pro. Positive amino acids were Lys and Arg. Negative 
amino acids were Asp and Glu. The stability curve was constructed by plotting the interaction 
value vs. the shift value.  Calculations were run with both parallel and antiparallel chain alignment. 
Proline (Pro) is usually considered to have a weak hydrophobic interaction, and since it accounts 
for more than 20% of the X and Y residues in Col108, it was considered as a hydrophobic residue 
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in the calculations. However, to check for imposed artifact calculations were also done under the 
assumption that proline does not belong to the hydrophobic class of the residues. 
 The foldon domain was treated as a ‘globular’ according to its conformation128. Residues 
at the core were considered sequestered from solvent exposure and unlikely to be involved in 
molecular interactions during the self-assembly. Thus, the only surface residues Gly-Tyr-Ile-Pro-
Glu-Ala-Pro-Arg-Asp-Asp-Gly-Glu-Trp along the linear trajectory extending from the triple helix, 
as determined by visual examination of a crystal structure of the T4 foldon domain (PDB Code 
1RFO), were included for consideration during calculation cycles.   
 The innate periodicity of the sequence of Col108 is reflected clearly in the periodic nature 
of the calculated interaction graphs. In a parallel alignment of the helices, the set of peaks with 
shift values at multiple of 123 (n×123) stands out as a unique staggering arrangement presenting 
optimal electrostatic and hydrophobic interactions (Figure 6-5A and B). The peaks are especially 
pronounced in the total and hydrophobic interaction graphs. The interaction graphs with 
calculations including or excluding Proline as a hydrophobic residue were compared (Figure 6-
5B). The set of peaks with n×123 is observed in calculations with and without the inclusion of 
proline. It was observed that the inclusion of Proline did not affect the periodic features of the 
outcome, but only increased the overall magnitude of the interaction because of the increased 
number of included residues. 
 Favorable interactions also exist at shift values of ~ n×24 but at a much lower magnitude. 
A closer inspection of the sequence indicates that the clusters of charged and hydrophobic residues 
are in approximate alignment when two helices are arranged with shift values of n×24.but this 
alignment is nearly completely out of phase when shift values are odd multiples of 12. The 
electrostatic interactions are particularly reflective of the favorable interactions at this small 
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stagger value, though the favorable interactions at n×123 shifting values are also evident. It is 
important to note here that the scale of the magnitude of the interactions is an arbitrary one. The 
peaks represent the potential of interaction, and the magnitude is in no way a representation of the 
absolute value of the stabilizing energy. The relatively lower magnitude of the electrostatic 
interactions can be related to the presence of fewer charged residues (75 residues) compared to 
hydrophobic ones (120 including Proline). Also, the contribution from interactions of like charges 
is set to be zero. The actual contribution of the electrostatic interactions to the stabilization of the 
fibrils may not be less than that of the hydrophobic interactions. It is the lack of a set of dominating 
peaks that set the electrostatic interactions apart from the hydrophobic interactions. 
By comparison, the interaction graph of an antiparallel arrangement of helices remarkably 
lacks any dominating peaks (Figure 6-5C). No one particular shift value dominate the graph; 
pointing towards no particular dominating chain staggering conformation in an antiparallel 
arrangement. 
The stability curve indicates when arranged with a mutual stagger of 123 residues the self-
association will be maximally stabilized through both the hydrophobic and the electrostatic 
interactions of the neighboring triple helices. In Col108 mini-fibrils, the resulting offsets allowed 
us to implicate the sequence repeat unit in Col108, which is composed of a total of 120 residues- 
a set of (GPP)4 and 108 residues long Col domain in proposing a model that was able to explain 








Figure 6-5 The interaction curves for optimal interactions; A, Interaction curve showing 
total interactions for parallel chain arrangement and the constituent electrostatic interactions (as 
labeled). B, interaction curves of the constituent electrostatic interactions from A, with or 
without inclusion of Pro residues (as labeled). C, interaction curve showing total interactions 
for antiparallel chain arrangement. 
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6.4.2 The Unit-staggered model of Col108 mini-fibrils   
Once a correlation was made between the observed banding pattern and pseudo-periodicity 
of the Col108 sequence, a self-assembly model of Col108 was proposed to reflect the banding 
pattern features of both negatively and positively stained mini-fibrils of Col108. (Figure 6-6).  
A fully folded Col108 triple helix is about ~ 120 nm in length, 1.5nm in diameter based on 
the crystal structures 59; each sequence unit corresponds to  the length of ~35nm. The foldon 
domain was a globular with a ~ 2-2.5nm diameter (the diameter of triple helix is ~1.5nm) and 
having an average of three negative charges on its surface based on the crystal structure128. The C-
terminal (GPP)4, together with the Cys-knots at the C and N termini is expected to contribute to 
about ~ 7 nm. Overall the region outside of the three sequence units is ~12 nm, or 0.3X the length 
of one sequence unit. 
 In the proposed model, the ~35nm d-period corresponds to a 123 residue pseudo-repeating 
sequence unit of Col108, and the C-terminal (GPP)4 nucleation sequence and the foldon domain 
form the major part of the 0.3d overhang. The mini fibrils formed through lateral association of 
the triple helices with a mutual staggering of one sequence unit at the N-terminus, creating an 
axially repeating d-periodicity of ~35nm having a light/overlap zone of 0.3d and dark/gap zone of 
0.7d, as observed in micrographs of negatively stained mini-fibrils of Col108 (Figures 6-1,-2 and 
-3). Not only does the number of residues of a sequence unit correspond well in size to the observed 
~35nm axial-periodicity, an offset of one sequence unit would lead to a perfect alignment of the 
sequence units of neighboring helices and produce maximal interactions between the charged and 
the hydrophobic residues. This corresponds well with the set of n×123 peaks depicted in the 
interaction curve graph (Figure 6-5A). The distribution of the charged residues within one 
sequence unit can be roughly characterized by two high charge-density regions with one being 
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slightly wider in range than the other (Figure 6-6A). In the unit-staggering assembly the spatial 
arrangement of these charged regions will be preserved and be identified as three pairs of dark 
thick-thin bands, with intercalating light strips of charge-free zones every 105nm (the approximate 
length of 3 sequence units) in the micrographs of positively stained mini fibrils (Figures  6-1(ii) 
and 6-2(ii)). Thus, the model mini-fibril using a stagger of 1-sequence unit can explain both 
banding patterns of negatively stained fibrils as well as the positively stained ones.  
While the repeating sequence architecture of Col108 warrants the alignment of the 
sequence units in any arrangement with an offset value of n × unit (n = 0, 1, 2, or 3), only the 1-
unit staggering one will generate the ~35nm d-periodicity. As shown in Fig., the exclusive 2-unit 
and 3-unit staggering arrangements will produce fibrils with an axial periodicity of 70 nm and 105 
nm, respectively. These fibrils will have staining patterns easily distinguishable from those shown 
in Figure 6-6 B and C. An exclusive 0-unit offset assembly, on the other hand, will not form 
staggered, long fibrils but only end-on-end stacks with one dimension approximately the length of 
a Col108 monomer. Arrangements of triple helices with a mixture of different n-unit offset values 
would, therefore, produce fibrils with gaps and overlaps of varied sizes arranged axially in 
undefined formations. TEM images of such fibrils would have unrecognizable negatively-stained 
banding patterns. Thus, the clear and persistent presence of the ~35nm d-period of the negatively 
stained mini-fibrils supports the 1-unit staggering as the predominant arrangement of the 











Figure 6-6: The model of the Col108 min-fibrils with ~35nm periodicity. A: the 1-unit staggering assembly of 
Col108 and the resultant negatively stained (top) and positively stained (bottom) banding patterns of the fibrils: the 
dark bars indicate stained area under TEM. The three sequence units of Col108 are shown in different shades of grey; 
the vertical lines show the locations of charged residues and the oval represents the foldon domain. A rod having three 
thick-thin charged zones indicated in black is superimposed on the Col108 to highlight the alignment of the charged 
residues, The double–headed arrows with solid lines mark one ~35nm d-period on the negatively stained fibril. The 
double-headed arrow with dotted lines mark the length of 3 sequence units (~ 105 nm) on the positively stained fibril. 
B: the model of 2-unit staggering mini-fibrils. The predicted negatively stained pattern of the fibrils is shown on top 
with the dark bar showing the stained gap region. The double–headed arrow marks one 70 nm d-period predicted for 
this arrangement. C: a model of fibrils of 3-unit staggering arrangement. The double–headed arrows mark one 105 
nm d-period predicted for this arrangement. This 3-unit arrangement can also represent the fibrils driven by the inter-




Col108 in the neutralized solutions self-assembles into the mini-fibrils with axial 
periodicity upon incubation at a higher temperature. The d-period in Col108 mini-fibrils was 
measured to be ~35nm. It is important to mention here that for the formation of periodic mini-
fibril of Col108, the triple helical conformation of Col108 was a pre-requisite. Fibrillogenesis trials 
using samples of Col108 that did not indicate the formation of the triple helix with distinct positive 
and negative peaks in CD spectrum of the starting sample resulted only in non-specific aggregates 
without any distinct banding pattern. 
The proposed model is supported by the structural details of the folded Col18 and the 
dominating and isolated interaction peaks with a parallel staggering of 123 residues in the 
interaction graph. The unit-staggering arrangement brings the interacting residues together and 
affords both maximal molecular interactions and uniqueness in the association pattern during 
assembly of mini-fibril of Col108.  
 The reason for observed self-assembled collagen-like fibrils of Col108 with d-periodicity 
is most likely due to the sequence periodicity which may also exist implicitly in natural collagens 
129 (Figure 6-7).The axial periodicity in Col108 fibrils is instigated by the built-in sequence 
periodicity and stabilized by the optimizing inter-helical interactions between the triple helices in 
a 1-unit staggered arrangement. Other factors in native collagen were also considered critical for 
fibril formation: the presence of hydroxyproline residues in the sequence and telopeptides. But, 
existing data has indicated the triple helices without Hyp and without telopeptides can also form 
D-periodic fibrils.  The mini-fibrils of Col108 may indicate that the sequence features of the triple 
helical domain are sufficient to code for the axially repeating periodicity of fibrils since Col108 
does not have either hydroxyproline residues or telopeptides. In summary, we can conclude that 
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self-assembly of Col108 proceeds via a lateral association between triple helices at a ~35nm 



















Figure 6-7 Comparison of self-assembly of Col108 and native collagen highlighting the similarity in assembly 




       The assembly of the mini-fibril is driven by non-covalent interactions between the triple 
helices, and the robust ~35nm periodicity indicates a highly specific molecular recognition 
mechanism. The residues of the Col domain were selected from type I collagen for their relatively 
high propensity for forming a triple helical conformation, yet they may also possess certain 
intrinsic properties of natural collagen which bring about strong molecular interactions between 
associating helices. The Col domain has a relatively high content of closely spaced negatively and 
positively charged residues. Sequences of charged residues such as KGE and KGD are likely 
involved in the formation of salt bridges between the three constituent chains of a triple helix 108, 
130 while others may contribute to interactions and molecular recognition between triple helix 
monomers during self-assembly. The charged residues within the Col domain are often present as 
pairs with opposite charges. When the clusters of charged residues are ‘aligned’ between 
neighboring triple helices, the attractive interactions between oppositely charged residues likely 
dominate over the repulsion of like charges. A similar distribution of paired charged residues has 
also been noted for native collagen21, 129, 131, although any attributions this distribution leads to the 
specific structure or functions of collagen were never explored. The periodic insertions of the 
(GPP)4 sequence may also play a structural role favoring the 1-unit staggered assembly; their 
specific involvement awaits to be defined.  
      The role of the foldon in the mini-fibrils is intriguing. The conformation of the foldon has a 
diameter of 2.5 nm, which is slightly larger than the diameter of ~ 1.5 nm of a typical triple helix 
and is packed with a defined bent angle with respect to the triple helical domain in the crystal 
structure of GPP10-foldon
128. However, the ‘kink’ between the two domains is likely caused by 
crystal packing, and the conformation is likely to be more flexible in solution. The smooth fibrils 
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of Col108 indicate the foldon can be accommodated, to a degree, in the packing of the helix. The 
fact that the foldon is located adjacent to the gap region may afford some spatial flexibility of the 
mini-fibrils to accommodate its larger size. On the other hand, the structural constraints of the 
foldon may impose certain destabilizing effects and impede the growth of the fibrils. The length 
of the mini-fibrils is limited to about 5-8 times the end-to-end lengths of the Col108 triple helix, 
which represents a limited extent of growth compared to that of collagen fibrils.   In the modeling 
of the 1-unit staggered fibrils, the negatively charged foldon domain appears to be surrounded by 
two positively charged residues from neighboring triple helices, which likely affords some 
stability. Such interactions, however, are not a determining factor for the structural specificity of 
the ~35nm axial periodicity, since there exist multiple clusters of positively charged residues on 
the Col108 triple helix. It is inconceivable to consider the foldon selectively anchors on these two 
particular positive residues without a more profound stabilizing mechanism in place, which brings 
the neighboring triple helices together and positions the foldon in the vicinity of the two residues.  
Distinct from native fibrillar collagens, Col108 contains no Hyp residues, nor does it have 
any telopeptides – two factors that have been under constant focus for their purported roles in the 
fibrillogenesis of native collagen. Despite its anticipated significance in collagen function and 
structure, the role of Hyp in fibrillogenesis has never been clearly defined. It was first proposed in 
the 1950s by Gustavson that Hyp may contribute to triple helix association through either a 
hydration network or direct intermolecular hydrogen-bonding interactions between triple helices 
132. The differences in crystal packing of the triple helical peptide (Pro-Pro-Gly)10, without Hyp 
residues, and peptides having a high Hyp content were taken as evidence that Hyp is involved in 
the organization of the water network surrounding the triple helix 48.  It was further suggested that 
the formation of higher molecular aggregates of the (Pro-Hyp-Gly)10 peptide is mediated by 
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hydrogen-bonded hydration networks involving Hyp 123. The concept of this hydration network, 
or more precisely the lack of it, was used to explain the deficiency of fibril assembly of a 
recombinant collagen without Hyp, from transgenic plants, under physiological conditions. 
Nonetheless, this unhydroxylated collagen was found to retain the ability to form fibrils with a 67 
nm banding pattern albeit only in buffers of low ionic strength48. Another recombinant type I 
collagen from a yeast expression system – the rho collagen – was also reported to form ‘normal 
fibrils in vitro’ despite the absence of the canonical hydroxylation pattern of Pro residues 133.  The 
Hyp content of rho collagen is only 50% of that of the type I collagen, and the locations of the 
Hyp are not specified. While the involvement of Hyp in a hydration network or a hydrogen-
bonding network may contribute to the stabilization of fibrils, it is not an intrinsic factor for 
structural specificity or formation of collagen fibrils. Factors affected by the interactions involving 
Hyp are likely to include the kinetics and the optimal conditions of the fibrillogenesis, or even the 
diameter of the fibrils 134. Still, the absence of Hyp does not abolish the ability of a triple helix to 
form a periodic assembly. The ability of Col108 to self-assemble into a highly ordered, axially 
periodic structure is consistent with the conclusion that Hyp is not a requirement for D-staggered 
packing during the fibrillogenesis of collagen.   
       The role of telopeptides in fibrillogenesis is another debated issue. The involvement of 
telopeptides in the early stages of fibrillogenesis was extrapolated to involve the binding of one 
telopeptide to the triple helical region of a nearby collagen monomer to place ‘the monomers in 
quarter D-period stagger,’ and to promote the formation of a structural nucleus essential for further 
growth of the fibrils 46. Removal of the telopeptides by proteolytic treatment of collagens isolated 
from tissues was found to affect the kinetics 41, 89 and change the morphology of the fibrils 135-137, 
or even prevent the formation of fibrils having a banding pattern 46. Other studies, however, 
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attributed the negative impacts on fibril formation caused by the removal of the telopeptides to the 
proteolytic removal of portions of the triple helix domain itself. Subsequently, collagen was found 
capable of forming fibrils even after complete removal of the telopeptides 138. This latter finding 
challenges the notion that the telopeptides are part of the ‘code necessary for recognition’ during 
fibrillogenesis. While Col108 does not have the N- or C-telopeptide of collagen, it does contain a 
foldon domain at the C-terminus. Although we consider it unlikely, further study is needed to 
elucidate any possible anchoring roles of this non-collagenous domain of Col108 during the self-
assembly of the mini-fibrils.  
       In comparison to other non-specific self-assemblies of triple helical peptides, the larger size 
and the rich collection of charged and hydrophobic residues of Col108, in addition to the repeating 
units of the sequences, may promote the structural specificity of the Col108 fibrils. The need for 
more diverse sequences than simple repeats of (Pro-Pro-Gly) or (Pro-Hyp-Gly) triads for the 
presence of structural features among self-assembled triple helices has long been recognized (13), 
and the effects of long-range sequence repeat beyond the (Gly-X-Y) triplets, is understudied. How 
to build such repeating units of sequences having a high variety of different residues into short 
synthetic peptides is challenging. The inclusion of multiple (Gly-Pro-Hyp) triplets is often 
necessary for the stability of short triple helical peptides19. The larger size of Col108 may provide 
more extensive contacts between the associating helices. Similar to protein folding in general, a 
critical amount of stabilizing interactions is often required for a specific structure to be selected 
over other competing forms, and this leads to its dominance in the free energy-driven, spontaneous 
process. We do not know if the 120 residues of one sequence unit represent, or is close to, the 
minimum size necessary to support an axially repeating structure during assembly, or if the number 
three represents a ‘golden number’ for the number of repeating sequence units. The relatively 
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simple and yet effective Col108 system offers the opportunity to address these and an array of 





















Index for TEM images of Col108 fibrils  
Incubation temperature Salt Conc . Incubation time Trial Number of files 
26°C 67.5mM NaCl       
          
    6 hours 1 12 
      2 2 
      3 18 
          
    24 hours 1 9 
      2 8 
      3 14 
37°C 67.5mM NaCl 6 hours     
      1 6 
      2 11 
    24 hours     
      1 11 
      2 9 
     
     
Index for AFM images of Col108 fibrils  
Incubation temperature Salt Conc . Incubation time 
Image 
folder 
Number of files 
37°C 67.5mM NaCl 24 hours 1 6 
      2 17 
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